Annexure-PFR - Environmental Clearances
Transcription
Annexure-PFR - Environmental Clearances
Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 1. EXECUTIVE SUMMARY 1.1 General M/s. Anlon Healthcare Pvt. Ltd. is a proposed small scale unit to be located at Survey No. 36/2, Near Toll Plaza on Rajkot-Gondal National Highway at Village Pipaliya, Taluka Gondal, Dist. Rajkot, Gujarat for manufacturing of various Synthetic Organic Chemicals (Pharmaceutical bulk drugs & Intermediates) with the total production capacity of 11.0 TPM. The proposed project is covered under Category 5(f)-B as per EIA Notification of Ministry of Environment & Forest (MoEF), dated 14/09/2006 and subsequent amendments. Therefore, unit requires obtaining Environmental Clearance from State Level Environment Impact Assessment Authority (SEIAA), Gujarat. 1.2 Salient Features of the plant site The project site is located at Rajkot District having all basic infrastructure facilities like availability of water, electricity, fuel, transport, telecommunication systems etc. Plant site is about 20 km away from Rajkot City which is well connected by road, rail and air to rest of India. The nearest human settlement from the site is at village Pipaliya at distance of 1.5 km. Availability of trained and skilled manpower in nearby areas. There is no protected area notified under the Wild Life (Protection) Act (1972) & Eco-sensitive area notified under Section 3 of the Environment (Protection) Act1986 exists within 10 Km radius areas from the Plant Site. Pre-Feasibility Report Page | 1 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 1.3 Proposed Products The unit proposes to manufacture various synthetic organic chemicals viz. Pharmaceutical Bulk Drugs & Intermediates with total production capacity of 11.0 TPM. Details of proposed products and by product are given in Table – 1 and Table – 2. Table 1: Details of Proposed Products: Sr. No. Capacity (TPM) Product 1. Bosentan 2. Rebamipide 3. Zaltoprofen 4. Candesartan 5. Valsartan 6. Pranlukast 7. Ticagrelor 8. Bazedoxifene Acetate 6.00 5.00 Total 11.00 Table 2: Details of Proposed By-Product: Sr. No. 1. By - Product Sodium Bisulfite Capacity (TPM) 7.6 Source Product 6 (APCE) 1.4 Resources Requirements Land: The total land acquired for the proposed unit is 4,971 sq. m. Water: The total fresh water requirement for various activities like domestic, gardening and industrial will be 8.3 KLD. The water requirement for the proposed project will be met by ground water source through own bore well. Power: Total 818 KVA (350 HP) power will be required and same will be procured from Paschim Gujarat Vij Company Limited (PGVCL). In addition to this, one DG Set of 250 KVA will be installed as stand-by and captive source of power. Fuel: Biofuel / Agricultural waste @ 180.0 TPM will be required for the steam boiler (2 TPH) and Thermic Fluid Boiler (2 Lac KCal.). Diesel @ 125 Lit/Hr. will be required for DG Set (250 KVA). Pre-Feasibility Report Page | 2 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Manpower: For the proposed unit about 30 personnel will be employed at the different level for the operation phase. Finance: Proposed unit is a small scale unit with capital investment of Rs. 800 Lacs. Capital cost towards Environmental protection measures for proposed project will be Rs. 150 Lacs. 1.5 Pollution Potential and Mitigative Measures Water Pollution: There will be wastewater generation from the manufacturing process, boiler, cooling and washing activities @ 16.6 KLD. This effluent will be collected and treated in Effluent Treatment Plant (ETP) comprising of primary, secondary & tertiary treatment. The treated effluent @16.2 KLD will be reused for process and boiler purposes. Air Pollution: There will be generation of the flue gas emissions from the steam boilers, Thermic fluid boiler and DG set. The unit will provide adequate air pollution control equipments to prevent flue gas emission. There will be process gas emission of SO2 from the manufacturing of product Pranlukast. Adequate scrubbing system like alkali scrubber will be provided for the control of process gas emission. Hazardous Waste: Hazardous waste will mainly be generated from effluent treatment plant as well as from manufacturing process viz. Organic Residue, Inorganic Residue and Spent Solvent. The ancillary source of hazardous waste generation will be discarded containers/bags from storage and handling of raw materials and spent/used oil generation from plant & machinery. The unit will provide an adequate designated area for the hazardous waste storage and will obtain membership of GPCB approved TSDF/CHWIF for the final disposal of hazardous waste. Greenbelt Development: The unit will develop green belt in about 1742.0 m2 area (35% of total land area) within the industrial premises with suitable plant species. Pre-Feasibility Report Page | 3 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 2. INTRODUCTION 2.1 Background M/s. Anlon Healthcare Pvt. Ltd. has been concentrating on manufacturing of Synthetic Organic Chemicals (Pharmaceutical Bulk Drugs & Intermediates) with the total installed capacity of 11 TPM. The unit has acquired a land at Survey No. 36/2, Near Toll Plaza on Rajkot-Gondal National Highway at Village Pipaliya, Taluka Gondal, Dist. Rajkot, Gujarat. The proposed project is covered under Category 5(f)-B as per new EIA Notification of Ministry of Environment & Forest (MoEF), dated 14/09/2006 and subsequent amendments. Therefore, unit requires obtaining Environmental Clearance from State Level Environment Impact Assessment Authority (SEIAA), Gujarat. As a part of application for obtaining Environmental Clearance, the unit requires to submit Form-1 and Pre-Feasibility Report of the proposed project. The objectives of the report are, a) To assess the feasibility of the proposed project. b) To identify various sources of pollution and anticipate the impacts of the proposed project on the environment. c) To suggest preventive and mitigation measures to minimize the adverse impacts and to prepare Environmental Management Plan (EMP). d) Propose the Terms of Reference to carry out EIA Study for the proposed project. 2.2 Nature of the Project The unit believes in sustainable development and equally concern about environment preservation and pollution control. The proposed project is a brown field project. The unit will provide an adequate Environmental Management System to meet desired norms of effluent discharge (Water + Air + Solid) as per the statutory recruitments for their proposed project and also will continue its endeavor for the pollution prevention and betterment of environment. 2.3 Project Proponent M/s. Anlon Healthcare Pvt. Ltd. is promoted by its directors Mr. Vaibhav Ramani and Mr. Punitkumar Rasadia. Details about the promoters are given below: Pre-Feasibility Report Page | 4 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 1. Mr. Vaibhav Ramani aged 30 years and has done Ph. D in Synthetic Organic Chemistry and looks after new product’s Research & Development and also manages product manufacturing with experience in operation and maintenance activities of plant handling. His core expertise is in research and development, pilot scale ups, plant scale ups, cost cutting in plant process, handling man power. With multifaceted experience of 7 years ranging from project execution, manufacturing, quality control, supply chain and marketing including setting strategic direction, driving financial and operational excellence and providing overall leadership. 2. Mr. Punitkumar Rasadia aged 29 years and has done Post Graduate in Organic Chemistry. He is directly related with company’s local and overseas sales and business development. He also handles business clients, meetings and also foresees future prospective and new ventures. He has an extensive experience of 10 years in finance, banking, mergers and acquisitions, strategic planning, restructuring operations, export marketing, international business relations, collaborations and joint ventures. He also looks after group’s financial reporting, investor relations, financing strategy including debt and equity rising, risk management and compliance, taxation strategy and planning. His core expertise is on strengthening strategic partnerships with clients, exploring global markets, increasing client relevance and evolving the company’s business model. 2.4 Need for the Project & Project Benefits The proposed project for manufacturing of Pharmaceutical Bulk Drugs & Intermediates requires substantial handling of raw materials, goods in process and finished goods. India's pharmaceutical industry is now the third largest in the world in terms of volume and 14th in terms of value. The contribution of Gujarat to India’s pharmaceutical and health sectors can be gauged by the fact that this Western State, having only 4 percent of the country’s population, which accounts for more than 40 per cent of medicines manufactured in India. Demand-Supply Gap Based on our informal survey of the market with potential customers and various traders, we have found that there is a big potential for the range of the products we are planning. API (Bulk drugs) & intermediates of API’s are normally not used in their basic form, so the demand for basic drugs emanates from formulation industries manufacturing medicines in various forms. As medicines are highly consumed in all Pre-Feasibility Report Page | 5 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. seasons, there are thousands of companies in India, which are manufacturing tablets, capsules & syrups of the proposed products. Imports vs. Indigenous production Based on the current cost of indigenous raw materials, unit will not have to import any raw materials as they are produced locally. This will make us very competitive against imported finished products and we will be able to increase the export of our finished products to the American and European markets. Export possibility Depending on the international demand of products we shall explore the possibility of exporting the products. Domestic/Export Markets Looking the anticipated demand of healthcare sector in domestic as well as global market and growing volume of pharmaceuticals industry, the proposed project to manufacture Pharmaceutical Bulk Drugs and & Drugs Intermediates, have no doubt for the guarantee of the product and its acceptability in the local and international market. Employment Generation (Direct and Indirect) due to project It is expected that the proposed project will require about 118 personnel. So, the project will provide direct employment to skilled workforce and indirect employment (transport, services deliveries etc.) to semi-skilled and unskilled workers. Thus, the project will have numerous induced impacts on society by generating employment opportunity and will lead to improvement in the social infrastructure in the region. Pre-Feasibility Report Page | 6 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 3. PROJECT LOCATION & SITE ANALYSIS 3.1 Location The project is to be located at Survey No. 36/2, Near Toll Plaza on Rajkot-Gondal National Highway at Village Pipaliya, Taluka Gondal, Dist. Rajkot, Gujarat. The location map of project site is shown in Figure-1 and the area covering 10 km radial distance from the project site is given as Figure-2. 3.2 Site Analysis & Infrastructure setup The salient features of the project site and study area are given below: 1. Location : Survey No. 36/2, Rajkot Gondal National Highway, District: Rajkot, Gujarat 2. Geographical Location : Latitude: 22° 5’ 29.18” N Longitude: 70° 46’ 58.44” E Topo Sheet: F42/K-16 3. Land use of Project site : Non Agricultural Land converted for the Industrial use 4. Infrastructure Setup : (Distances mentioned below are aerial distances) 5. 6. (a) Town / Habitation : Gondal @ 14 km, South (b) City : Rajkot @ 20 km, North (c) Highways : NH 8-B @ 0.6 km, West (d) Railway Station : Ribda Railway Station @ 5 km, NNE (e) Sea Coast : Gulf of Kutch @ 100 km, WNW (f) Domestic Airport : Rajkot @ 24 km, North (g) International Airport : Ahmedabad @ 230 km, ENE (h) Defence installations : None Place of Interest / Tourist : Riverside Palace (Gondal) @ 14 km places South Protected areas within 10 Km radius from the Plant Site (if, any) : There is no protected area notified under the Wild Life (Protection) Act (1972) & Eco-sensitive area notified under Section 3 of the Environment (Protection) Act1986 exists within 10 Km radius areas from the Plant Site. 7. Displacement of population : None 8. Seismic Zone : The area is falling in Zone- III having moderate Damage Risk Zone (MSK- VII). Pre-Feasibility Report Page | 7 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Figure - 1: Location of Project Site Location of Rajkot District in Gujarat Location of Project Site in Rajkot District Pre-Feasibility Report Page | 8 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Figure - 2: Google Image of 10 km Radial Distance from the Project Site Legends: Project Site 1 Pipaliya Village 5 Mahika Mota Village 2 Ribda Village 6 Bharudi Village 3 Shahpar Village 7 Mungavavdi Village 4 Bhunava Village 3.3 Details of Alternative Sites and Justification of Site Selection Pre-Feasibility Report Page | 9 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Unit has already acquired land to establish the proposed unit at Gondal, Dist. Rajkot. and site selection was guided by many factors like infrastructure, availability of land, water sources, fuel, transportation, power availability etc. Specific site selection criteria for the proposed project of M/s. Anlon Healthcare Pvt. Ltd. are given below; The project site is located in the Rajkot District having all basic infrastructure facilities like availability of water, electricity, fuel, transport, telecommunication systems etc. Plant site is about 20.0 km away from Rajkot City which is well connected by road, rail and air to rest of India. The nearest human settlement from the site is Pipaliya village at distance of 1 km in WNW direction. Availability of trained and skilled manpower into nearby areas. There is no protected area notified under the Wild Life (Protection) Act (1972) & Eco-sensitive area notified under Section 3 of the Environment (Protection) Act1986 exists within 10 Km radius areas from the Plant Site. Pre-Feasibility Report Page | 10 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 4. PROJECT DESCRIPTION 4.1 Details of Products and Production Capacity The unit proposes to manufacture various Pharmaceutical Bulk Drugs & Intermediates with total production capacity of 11 TPM. Details of proposed products and by products along with production capacity are given hereunder in Table – 3(a), Table – 3(b) and Table 4. Table – 3(a): List of Proposed Products Sr. No. Name of Products 1. Bosentan 2. Rebamipide 3. Zaltoprofen 4. Candesartan 5. Valsartan 6. Pranlukast 7. Ticagrelor 8. Bazedoxifene Acetate Capacity (MT/Month) 6.0 5.0 Total 11.0 Table - 3(b): List of Proposed By-Product: Sr. No. 1. By - Product Capacity (TPM) Sodium Bisulfite 7.6 Table – 4: Details of Proposed Products Sr. No. Name of Products 1. Bosentan 2. Rebamipide IUPAC Name Synonym Use of Product 4-tert-butyl-N-[6(2hydroxyethoxy)5-(2methoxyphenoxy) -2-(pyrimidin-2yl)pyrimidin-4yl]benzene-1sulfonamide N-(4Chlorobenzoyl)-3- 4-(1,1-Dimethylethyl)-N[6-(2-hydroxyethoxy)-5(2methoxyphenoxy)[2,2'bipyrimidin]-4yl]benzenesulfonamide Used in the treatment of pulmonary artery hypertension 2-(4Chlorobenzoylamino)-3- Used for mucosal protection, Pre-Feasibility Report Page | 11 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. (2-oxo-1,2[2(1H)-quinolinon-4dihydroquinolin-4- yl]propionic acid yl)alanine 3. 4. 5. 6. 7. 8. Zaltoprofen Candesartan Valsartan 10,11-Dihydro-αmethyl-10oxodibenzo[b,f]thi epin-2-acetic Acid 2-ethoxy-1-({4-[2(2H-1,2,3,4tetrazol-5yl)phenyl]phenyl} methyl)-1H-1,3benzodiazole-7carboxylic acid (S)-3-methyl-2(N-{[2'-(2H1,2,3,4-tetrazol-5yl)biphenyl-4yl]methyl}pentana mido)butanoic acid N-[4-oxo-2-(1Htetrazol-5-yl)-4HPranlukast chromen-7-yl]-4(4-phenylbutoxy) benzamide (1S,2S,3R,5S)-3[7-[(1R,2S)-2(3,4Difluorophenyl) cyclopropylamino ]-5-(propylthio)3HTicagrelor [1,2,3]triazolo[4,5 -d]pyrimidin-3-yl]5-(2hydroxyethoxy) cyclopentane-1,2diol 1-{4-[2-(1Azepanyl)ethoxy] Bazedoxifene benzyl}-2-(4Acetate hydroxyphenyl)3-methyl-1Hindol-5-ol acetate Pre-Feasibility Report Page | 12 healing of gastro duodenal ulcers, and treatment of gastritis 2-(10-Oxo-10,11Anti-inflammatory dihydrodibenzo[b,f]thiepi drug used for n-2-yl)propanoic acid pain relief 2-(ethyloxy)-1-{[2'-(1Htetrazol-5-yl)biphenyl-4yl]methyl}-1Hbenzimidazole-7carboxylic acid Used for the treatment of hypertension (2S)-3-Methyl-2(pentanoyl{[2'-(1Htetrazol-5-yl)-4biphenylyl]methyl}amino )butanoic acid Used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. Used for treatment of allergy in asthmatic patients Used for treatment of thrombotic events i.e. stroke, heart attack 4-Oxo-8-(4-(4phenylbutoxy)benzoyla mino)-2-(tetrazol-5-yl)4H-1-benzopyran (1S,2S,3R,5S)-3-[7{[(1R,2S)-2-(3,4Difluorophenyl)cyclopro pyl]amino}-5(propylsulfanyl)-3H[1,2,3]triazolo[4,5d]pyrimidin-3-yl]-5-(2hydroxyethoxy)-1,2cyclopentanediol 1-{4-[2-(Azepan-1yl)ethoxy]benzyl}-2-(4hydroxyphenyl)-3methyl-1H-indol-5-ol acetate Selective estrogen receptor modulator Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 4.2 Land and Project Layout The total land acquired for the proposed unit is @ 4,971.0 m2. Out of total land available, the unit will develop @ 1,742 m2 (35%) area for the green belt/ gardening for the betterment of the environment. The detailed break-up of the land is given in Table - 5 and Key Plan & Plant Layout is shown in Drawing - 1. Table - 5: Break-up of Plot Area Sr. No. Area (m2) Particular % of Total Land 1. Process Plant 500.0 10.06 2. Raw Material & Product Storage 300.0 6.04 3. Utility 154.0 3.10 4. Effluent Treatment Plant 125.0 2.51 5. Green Belt 1,742.0 35.04 6. Roads 742.9 14.94 7. Administrative Building 417.0 8.39 8. Paved Area 640.1 12.88 9. API Block 350.0 7.04 100.00 Total 4,971.00 Pre-Feasibility Report Page | 13 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Drawing - 1: Key Plan & Plant Layout Pre-Feasibility Report Page | 14 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 4.3 Resource Requirements [A] Water The water requirement for the proposed project will be met by ground water supply through own bore well. The total fresh water requirement for various domestic, gardening & industrial activities will be 8.3 KLD. [B] Power Total 818 KVA (350 HP) power will be required for the proposed project and same will be procured from PGVCL (GEB). In addition to this, 1 DG Set of 250 KVA will be installed as stand-by and captive source of power. [C] Fuel For the proposed project Bio-fuel/ Agricultural waste will be required for the steam boilers (2 TPH) & Thermic Fluid Boiler (2 Lac Kcal.) and diesel will be required for stand-by DG Set. The details of fuel requirement are given in Table - 6. Table - 6: Details of Fuel Requirement Sr. No. Type of Fuel 1 Bio-fuel/ Agricultural waste 2 Diesel [D] Utility Requirement Steam boiler (2 TPH) & Thermic Fluid Boiler (2 Lac KCal) 180 TPM DG Set 125 Lit/Hr. Manpower The manpower is one of the main resource requirements to operate and maintain the plant in a better and efficient way. Total 30 personnel will be required for the proposed project in the operation phase. Details of personnel requirement at various cadres are as tabulated in Table 7 below: Pre-Feasibility Report Page | 15 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Table - 7: Details of Manpower Requirement Description Management Supervisory Staff Staff Administration Production & allied services Stores & Dispatch Others Total 4.4 Clerks Company Workers Contractor Workers Total 1 0 1 1 1 4 2 4 0 8 8 22 0 0 1 1 2 4 0 0 0 0 0 0 3 4 2 10 11 30 Details of Manufacturing Process 1. BOSENTAN a) Manufacturing Process 5-(2-Methoxyphenoxy)-4, 6-dichloro-2-(pyrimidin-2-yl) pyrimidine reacts with 4-(tertButyl)benzene-1-sulfonamide in presence of Sodium Bicarbonate to give 4-substitutes pyrimidine which further couples with Ethylene glycol in presence of Sodium Methoxide in Toluene and Methylene Dichloride solvent media to give desired Bosentan. Pre-Feasibility Report Page | 16 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. b) Reaction Chemistry Reaction Chemistry Chemical Name Gram/Mole Gram/Mole NaHCO3 5-(2Methodyphenoxy)4, 6-dichloro-2(pyrimidin-2yl)pyrimidine 4- (tert-Buty) benzene-1sulfonamide Ethylene Glycol Water Sodium Bicarbonate 349 213 62 54 84 Reaction Chemistry Chemical Name 3H2O 2NaCl CO2 CH3OH H2O Bosentan Sodium Chloride Carbon Dioxide Methanol Water 551 117 44 32 18 Pre-Feasibility Report Page | 17 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. c) Process Flow Diagram 5-(2-Methoxyphenoxy)4,6-dichloro-2(pyrimidin-2-yl) pyrimidine : 4-(tert-Butyl)benzene1-sulfonamide : 102 Ethylene glycol : 30 Sodium Methoxide : 26 Sodium Bicarbonate : 41 Toluene (Fresh) : Toluene (Recovered) Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) 167 Bosentan : 200 Toluene : (Recovered) 1,570 Toluene Loss : Methylene Dichloride : (Recovered) 50 100 Effluent : 1,751 : 1,570 114 : 67 Organic Residue : Process : Emissions (CO2) : 768 Water : 1,670 Total : 4,541 Total : 4,541 Capacity, TPM 6.00 Batch size, Kg 200 Working Days 26 Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. 2. 5-(2-Methoxyphenoxy)4,6-dichloro-2-(pyrimidin2-yl) pyrimidine 4-(tert-Butyl) benzene-1sulfonamide 167.0 0.835 5.01 Reactant 102.0 0.510 3.06 Reactant 3. Ethylene glycol 30.0 0.150 0.90 Reactant 4. Sodium Methoxide 26.0 0.130 0.78 Reagent Pre-Feasibility Report Page | 18 768 Methylene : Dichloride (Loss) Stage 1 d) Summary of Mass Balance Sr. No. 67 21 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 5. Sodium Bicarbonate 6. Toluene (Fresh) 7. Toluene (Recovered) 8. 9. 10. Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) Water Total 41.0 0.205 1.23 Reactant 100.0 0.500 3.00 Solvent 1,570.0 7.850 67.0 0.335 768.0 3.840 23.04 1,670.0 8.350 50.10 4,541.0 47.10 Solvent Recovered 2.01 Solvent Solvent Recovered 22.705 136.23 Output 1. Bosentan 2. 3. Finished Product Solvent 47.10 Recovered 2.01 Solvent Loss Solvent 23.04 Recovered 200.0 1.000 Toluene (Recovered) 1,570.0 7.850 67.0 0.335 768.0 3.840 50.0 0.250 1.50 Solvent Loss 6. Toluene Loss Methylene Dichloride (Recovered) Methylene Dichloride Loss Effluent 1,751.2 8.756 7. Organic Residue 113.7 0.569 8. Process Emissions (CO2) 21.1 0.105 52.53 To ETP Organic HW 3.41 (CHWIF) 0.63 Atmos. Loss Total 4,541.0 4. 5. 6.00 22.705 136.23 Pre-Feasibility Report Page | 19 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 2. REBAMIPIDE a) Manufacturing Process Stage-1: Charge 4-bromo-3-oxo-N-phenylbutanamide in sulfuric acidand warm reaction mass up to 45-50 oC. Upon completion of reaction quench reaction mass in water. Fitler slurry to obtain Bromomethyl-1,2-dihydroquinoline-2-one. Stage-2: Charge Diethyl 2-aminomalonate Hydrochloride and Triethyl amine in Methylene Dichloride. Stir reaction mass at 10-15 °C. Charge 4-chloro Benzoyl Chloride dropwise. Upon completion of reaction add water and separate layers. Distill out Methylene Dichloride to get diethyl 2-(4-chlorobenzamido)malonate. Stage-3: Anhydrous Methanol and Sodium Methoxidewere charged in reactor and the mixture was cooled down to below 5°C. After adding diethyl Diethyl 2-[4(chlorobenzoyl)amino]Malonate, the resulting solution was stirred at below 5°C for one hour. 4-Bromomethyl-1,2-dihydroquinoline-2-onewas added to the mixture and the resulting solution was stirred at the room temperature for 16 hours to produce an intermediate, ethyl 2-(4- chlorobenzoylamino)-2-ethoxycarbonyl-3-[2(1H)-quinolinon-4yl]propionate. Stage-4: After the completion of the reaction, sodium hydroxide was dissolved in 30 ml of purified water and this aqueous solution was added to the above solution, which was then stirred at the room temperature for about 2 hours. Subsequently, the resulting solution was warmed to about 60°C and stirred for 2 hours to complete the reaction. Methanol was removed through vacuum concentration, and purified water and conc. HCl were added to the residue for crystallization. Pre-Feasibility Report Page | 20 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. b) Reaction Chemistry Stage-1 Reaction Chemistry Chemical Name Gram/Mole H2SO4 4-bromo-3-oxo-Nphenylbutanamide Sulfuric Acid 256 98 4-(bromomethyl) quinolin-2(1H)one 238 H2SO4 H2O Sulfuric Acid Water 98 18 Stage-2 Reaction Chemistry Chemical Name Gram/Mole 2HCl diethyl 2aminomalonate hydrochloride 4chlorobenzoyl chloride triethyl amine diethyl 4chlorobenzamido malonate Hydro Chloric Acid triethyl amine 211 175 101 313 73 101 Pre-Feasibility Report Page | 21 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Stage-3 Reaction Chemistry Chemical Name Gram/Mole NaOMe 4-(bromomethyl) quinolin-2(1H)one diethyl 4chlorobenzamido malonate Sodium Methoxide 238 313 54 diethyl 2-(4chlorobenzamido)-2((2-oxo-1,2dihydroquinolin4-yl) 471 NaBr MeOH Sodium Bromide Methanol 102 32 Stage-4 Reaction Chemistry Chemical Name Gram/Mole Pre-Feasibility Report Page | 22 NaOH 2H2O 2EtOH diethyl 2-(4chlorobenzamido)-2-((2oxo-1,2-dihydroquinolin-4yl) Sodium Hydroxide Water Rebamipide Ethanol 471 40 36 371 92 CO2 NaOH Carbon Sodium Dioxide Hydroxide 44 40 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. c) Process Flow Diagram 4-bromo-3oxo-N-phenyl : butanamide 164 Sulfuric Acid : 150 Water : Total : Diethyl 2aminomalonate : Hydrochloride 4-chloro benzoyl : chloride Triethyl Amine : Methylene Dichloride : (Fresh) Methylene Dichloride : (Recovered) Bromomethyl-1,2dihydroquinoline- : 2-one 150 Effluent : 900 750 Organic Residue : 14 1,064 Total : 1,064 Diethyl 2-(4chlorobenzamido) : malonate Methylene Dichloride : (Recovered) Methylene : Dichloride (Loss) 149.1 123.6 155.1 208.8 112 8 Stage 2 8.0 Effluent : 306.7 Organic Residue : 12.3 Total : 647.8 112 Water : 100 Total : 647.8 Intermediate : from Stage 1 150 Intermediate Product from : Stage 2 208.8 Sodium Methoxide Methanol (Fresh) Methanol (Recovered) Acetic Acid (Fresh) Acetic Acid (Recovered) Stage 1 : 76.5 : 31 : diethyl 2-(4chlorobenzamido)2- ((2-oxo-1,2: dihydroquinoline4 yl)methyl) malonate Methanol : (Recovered) Stage 3 282 1169 Methanol (Loss) : 50.1 1169 Acetic Acid : (Recovered) 115 : 5.0 Effluent : 66 : 115 Organic Residue : 73.2 Total : 1,755.3 Total : 1,755.3 Pre-Feasibility Report Page | 23 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Intermediate : from Stage 3 Sodium : Hydroxide Hydrochloric : Acid 282 Rebamipide : 214.8 55 Effluent : 627.5 Organic Residue : 9.2 Stage 4 40 Water : 500 Total : 877 Process : Emission Total : Gross Input : 4,344 Gross Output : 25.5 877 4,344 d) Summary of Mass Balance Capacity, TPM 6.00 Batch size, Kg 215 Working Days 26 Stage - 1 Sr. No. Name of Raw Material Quantity Remarks Kg/Batch Kg/Kg of Product 164.0 0.764 4.58 Reactant 150.0 0.698 4.19 Reactant 750 3.492 20.95 1,064.0 4.953 29.72 150.0 0.698 900.0 4.190 14.0 0.065 1,064.0 4.953 TPM Input 2. 4-bromo-3-oxo-Nphenylbutanamide Sulphuric acid 3. Water 1. Total Output Bromomethyl-1,21. dihydroquinoline-2one 2. Effluent 3. Organic Residue Total Stage – 2 Pre-Feasibility Report Page | 24 4.19 Used in 3rd Stage 25.14 To ETP Organic HW 0.39 (CHWIF) 29.72 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. 2. 3. 4. 5. 6. Diethyl 2aminomalonate Hydrochloride 4-chloro benzoyl chloride Triethyl Amine Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) Water Total Output Diethyl 2-(41. chlorobenzamido) malonate Methylene Dichloride 2. (Recovered) Methylene Dichloride 3. Loss 4. Effluent 5. Organic Residue Total 149.1 0.694 4.16 Reactant 123.6 0.575 3.45 Reactant 155.1 0.722 4.33 Reactant 8.0 0.037 0.22 Solvent 112.0 0.521 3.13 Solvent Recovered 100.0 0.466 2.79 647.8 3.016 18.09 208.8 0.972 5.83 Used in Next Stage 112.0 0.521 3.13 Solvent Recovered 8.0 0.037 0.22 Solvent Loss 306.7 1.428 12.3 0.057 647.8 3.016 8.56 To ETP Organic H/W 0.34 (CHWIF) 18.09 Stage – 3 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. 2. 3. Bromomethyl-1,2dihydroquinoline-2one Diethyl 2-(4chlorobenzamido) malonate Sodium Methoxide 150.0 0.698 4.19 Reactant 208.8 0.972 5.83 Reactant 76.5 0.356 2.14 Reactant Pre-Feasibility Report Page | 25 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 4. 5. 6. 7. Methanol (Fresh) Methanol (Recovered) Acetic Acid (Fresh) Acetic Acid (Recovered) Total Output diethyl 2-(4chlorobenzamido)-21. ((2-oxo-1,2dihydroquinoline-4yl)methyl)malonate Methanol 2. (Recovered) 3. Methaol Loss Acetic Acid 4. (Recovered) 5. Effluent 6. Organic Residue Total 31.0 0.144 0.86 Solvent 1,169.0 5.442 5.0 0.023 0.14 Solvent 115.0 0.535 3.21 Solvent Recovered 1,755.3 8.172 282.0 1.313 7.88 Used in Next Stage 1,169.0 5.442 32.65 Solvent Recovered 50.1 0.233 1.40 Solvent Loss 115.0 0.535 3.21 Solvent Recovered 65.99 0.307 73.2 0.341 1,755.3 8.172 32.65 Solvent Recovered 49.03 1.84 To ETP Organic H/W 2.04 (CHWIF) 49.03 Stage – 4 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 2. diethyl 2-(4chlorobenzamido)-2((2-oxo-1,2dihydroquinoline-4yl)methyl)malonate Sodium hydroxide 3. Hydrochloric Acid 4. Water 1. Total 282.0 1.313 7.88 Reactant 55.0 0.256 1.53 Reactant 40.0 0.186 1.12 For Crystallization 500.0 2.328 13.96 877.0 4.083 24.49 Output 1. Rebamipide 214.8 1.000 2. Effluent 627.5 2.921 Pre-Feasibility Report Page | 26 6.00 Finished Product 17.53 To ETP Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 3. 4. Organic Residue Process Emission (CO2) Total Organic H/W (CHWIF) 9.2 0.043 0.25 25.5 0.119 0.71 Atmospheric Loss 877.0 4.083 24.49 Pre-Feasibility Report Page | 27 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 3. ZALTOPROFEN a) Manufacturing Process Stage-1: Charge Methanol, 2-(2-(phenylthio)-5-propionylphenyl)acetic acid and Sulfuric acid. Heat reaction mixture for 65 oC for 5 hours. After completion distill out methanol cool reaction mixture and add toluene and water. Separate layers. Wash organic layer with Sodium Carbonate solution. Evaporate organic layer under vacuum. To the reaction mass charge Trimethylorthoformate, Zinc dust and heat at 50 oC. Charge bromine slowly. Upon completion cool the reaction mass and charge zinc dust. Heat reaction mass at 100 oC. Upon completion cool reaction mass and charge DM water and toluene. Separate layers. Wash organic layer with 20 % Sodium hydroxide solution. Acidify aqueous layer with dilute sulfuric acid. Cool reaction mixture to and filter slurry yield 5-(1-Carboxyethyl)-2-(phenylthio)phenylacetic acid. Stage-2: Polyphosphoric acid is charged in reactor, followed by 5-(1-Carboxyethyl)-2(phenylthio)phenylacetic acid. Charge Ethylene Dichloride and heat reaction mass to reflux at 83-85 oC for 30 minutes. Distill out Ethylene Dichloride. Reflux reaction mass for more 2 hours. After completion of reaction cool reaction mass to room temperature and quench the reaction mass in water. Heat reaction mass to 68-72 oC for 30 minutes. Separate layers and cool organic layer at 0-5 oC for 2 hours. Filter the product. Stage-3: Charge water and Ethanol in reactor and stir for 30 minutes. Charge Zaltoprofen crude at room temperature. Charge sodium carbonate solution slowly and stir for 1 hour. Neutralize reaction mass with Acetic acid. Filter the reaction mass and transfer filtrate to reactor. Charge more acetic acid and stir for 1 hour. Filter product and wash with DM water. Pre-Feasibility Report Page | 28 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. b) Reaction Chemistry Stage-1 Reaction Chemistry Br 2-(2-(phenylthio)-5Chemical Name propionylphenyl)acet ic acid Gram/Mole 300.37 H2O Zn Bromine Zinc Dust Trimethyl Orthoformate Water 159.81 65.38 106.12 16 2-(3(carboxymethyl)-4(phenylthio)phenyl ) propanoic acid 316 Br Zn Bromine Zinc Dust Trimethyl Orthoformate 159.81 65.38 106.49 Stage-2 Reaction Chemistry Chemical Name Gram/Mole 2H3PO4 EDC H2O 2-(3-(carboxymethyl)-4(phenylthio) phenyl) propanoic acid Polyphosphoric acid Ethylene Dichloride Water 316 196 98 18 Stage-3 Reaction Chemistry Ethanol Acetic Acid Chemical Name Gram/Mole Zaltoprofen (Crude) Zaltoprofen (Pure) 298 298 Pre-Feasibility Report Page | 29 P2O5 EDC 5H2O Zaltoprofen (Crude) Phosphorus Pentoxide Ethelyne Dichloride Water 298 142 98 90 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. c) Process Flow Diagram 2-(2-(phenylthio)-5propionylphenyl) acetic acid : 28 Methanol (Fresh) : 13 Methanol (Recovered) : 155 Sulfuric acid : 2.8 Sodium Carbonate : Trimethyl Ortho Formate 2-(3-(carboxymethyl)-4(phenylthio)phenyl) propanoic acid : 28 5.2 Methanol (Recovered) : 155 : 24.4 Methanol Loss : 13 Zinc Dust : 1.2 Toluene (Recovered) : 78 Bromine : 18.2 Toluene Loss : 6 Sodium Hydroxide : 15.4 Effluent : 280.4 Toluene (Fresh) : 6 Organic Residue : 6.6 Toluene (Recovered) : 78 Water : 219.8 Total : 567 Total : 567 2-(3-(carboxymethyl)-4(phenylthio)phenyl) propanoic acid : 28 Zaltoprofen (Crude) : 23.7 Polyphosphoric acid : 112 Ethylene Dichloride (Recovered) : 67 Ethylene Dichloride (Fresh) : 3 Ethylene Dichloride (Loss) : 3 Ethylene Dichloride (Recovered) : 67 Effluent : 196 Water : 82.5 Organic Residue : 3 Total : 292.5 Total : 292.7 Zaltoprofen (Crude) : 23.7 Zaltoprofen (Pure) : 19.8 Ethanol (Fresh) : 2.9 Ethanol (Recovered) : 53.0 Ethanol (Recovered) : 53 Ethanol (Loss) : 2.0 Acetic Acid (Fresh) : 1.7 Acetic Acid (Recovered) : 16.0 Stage 1 Stage 2 Stage 3 Acetic Acid (Recovered) : 16.0 Acetic Acid (Loss) : 0.7 Sodium Carbonate : 5.1 Effluent : 82.2 : : Organic Residue : 6.4 Water 79.4 Process Emission (CO2) : 1.7 Pre-Feasibility Report Page | 30 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Total : 181.8 Total : 181.8 Gross Input : 1,041.3 Gross Output : 1,041.5 d) Summary of Mass Balance Capacity, TPM 6.0 Batch size, Kg 19.8 Working Days 26 Stage - 1 Quantity Sr. No. Name of Raw Material Kg/Batch Kg/Kg of Product 1. 2-(2-(phenylthio)-5propionylphenyl)acetic acid 28.0 1.414 8.48 Reactant 2. Methanol (Fresh) 13.0 0.657 3.94 Solvent 3. Methanol (Recovered) 155.0 7.828 4. Sulfuric acid 2.8 0.141 0.85 Reagent 5. Sodium Carbonate 5.2 0.263 1.57 Neutralization 6. Trimethyl Ortho Formate 24.4 1.232 7.39 Reactant 7. Zinc Dust 1.2 0.061 0.36 Reactant 8. Bromine 18.2 0.919 5.51 Reactant 9. Sodium Hydroxide 15.4 0.778 4.67 Neutralization 10. Toluene (Fresh) 6.0 0.303 1.82 Solvent 11. Toluene (Recovered) 78.0 3.939 12. Water 219.8 11.101 66.61 567.0 28.636 171.82 1. 2-(3-(carboxymethyl)4-(phenylthio)phenyl) propanoic acid 28.0 1.414 8.48 Used in Next Stage 2. Methanol (Recovered) 155.0 7.828 46.97 Solvent Recovered Remarks TPM Input Total 46.97 Solvent Recovered 23.64 Solvent Recovered Output Pre-Feasibility Report Page | 31 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 3. Methanol Loss 13.0 0.657 4. Toluene (Recovered) 78.0 3.939 5. Toluene Loss 6.0 0.303 6. Effluent 280.4 14.162 7. Organic Residue 6.6 0.333 2.00 567.0 28.636 171.82 Total 3.94 Solvent Loss 23.63 Solvent Recovered 1.82 Solvent Loss 84.97 To ETP Organic H/W (CHWIF) Stage-2 Quantity Sr. No. Name of Raw Material Kg/Batch Kg/Kg of Product 28.0 1.414 8.48 Reactant 112.0 5.657 33.94 Reactant 3.0 0.152 0.91 Solvent 67.0 3.384 20.30 Solvent Recovered 82.5 4.167 25.00 292.5 14.774 88.63 23.7 1.197 7.18 Used in Next Stage 67.0 3.384 20.30 Solvent Recovered 3.0 0.152 195.5 9.874 3.3 0.167 1.00 292.5 14.774 88.63 TPM Remarks Input 1. 2-(3-(carboxymethyl)4(phenylthio)phenyl)pro panoic acid 2. Polyphosphoric acid 3. 4. 5. Ethylene Dichloride (Fresh) Ethylene Dichloride (Recovered) Water Total Output 1. 2. 3. Zaltoprofen (Crude) Ethylene Dichloride (Recovered) Ethylene Dichloride (Loss) 4. Effluent 5. Organic Residue Total Pre-Feasibility Report Page | 32 0.91 Solvent Loss 59.24 To ETP Organic H/W (CHWIF) Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Stage-3 Quantity Sr. No. Name of Raw Material Kg/Batch Kg/Kg of Product 23.7 1.197 7.18 Reactant 2.9 0.146 0.88 Solvent 53.0 2.677 1.7 0.086 0.52 Solvent 16.0 0.808 4.85 Solvent Recovered 5.1 0.258 1.55 Reactant 79.4 4.010 24.06 181.8 9.182 55.1 TPM Remarks Input 1. Zaltoprofen (Crude) 2. Ethanol (Fresh) 3. Ethanol (Recovered) 4. Acetic Acid (Fresh) 5. Acetic Acid (Recovered) 6. Sodium Carbonate 7. Water Total 16.06 Solvent Recovered Output 1. Zaltoprofen 19.8 1.000 6.00 Finished Product 2. Ethanol (Recovered) 53.0 2.677 16.06 Solvent Recovered 3. Ethanol (Loss) 2.0 0.101 0.61 Solvent Loss 4. Acetic Acid (Recovered) 16.0 0.808 4.85 Solvent Recovered 5. Acetic Acid (Loss) 0.7 0.035 0.21 Solvent Loss 6. Effluent 82.2 4.153 7. Organic Residue 6.4 0.322 1.93 8. Process Emission (CO2) 1.7 0.086 0.52 Atmospheric Loss 181.8 9.182 55.1 Total 24.92 To ETP Organic H/W (CHWIF) Pre-Feasibility Report Page | 33 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 4. CANDESARTAN a) Manufacturing Process Stage-1: Charge Methylene Dichloride and Trityl Amine at 10 oC. Charge solution of Trityl Chloride in Methylene Dichloride slowly at 10 oC. Stir for 1-2 hours and charge water to separate organic layer. Concentrate organic layer under vacuum and charge ethyl acetate. Cool fo 5 oC and filter Trityl Candesartan and dry at 50 oC in dryer. b) Reaction Chemistry Reaction Chemistry Chemical Name Gram/Mole Candesartan Trityl Chloride Triethyl amine 440 278 101 Reaction Chemistry Chemical Name Gram/Mole Pre-Feasibility Report Page | 34 HCl Trityl Candesartan Triethyl amine Hydro Chloric Acid 682 101 36 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. c) Process Flow Diagram Candesartan : 91 Trityl Chloride : 64 Triethyl amine : 37 Methylene Dichloride : (Fresh) 15 Methylene Dichloride : (Recovered) 370 Ethyl Acetate (Fresh) : 40 Ethyl Acetate : (Recovered) Water : Trityl Candesartan Methylene Dichloride (Recovered) Methylene Dichloride (Loss) Ethyl Acetate (Recovered) Ethyl Acetate (Loss) : 134 : 370 : 15 : 620 : 40 620 Effluent : 154 110 Organic Residue : 14 Stage 1 Total : 1,347 Total : 1,347 d) Summary of Mass Balance Capacity TPM 6.00 Batch size Kg 134 Working Days 26 Sr. No. Quantity Kg/Kg Kg/Batc of h Produc t Name of Raw Material TPM Remarks Input 1. Candesartan 91.1 0.680 4.08 Reactant 2. Trityl Chloride 63.8 0.476 2.85 Reactant 3. 37.3 0.279 1.67 Reactant 15.0 0.112 0.67 Solvent 370.0 2.761 6. Triethyl amine Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) Ethyl Acetate (Fresh) 40.0 0.299 7. Ethyl Acetate (Recovered) 620.0 4.627 8. Water 110.0 0.821 1,347.2 10.1 4. 5. Total Solvent Recovered 1.79 Solvent Solvent 27.76 Recovered 4.92 16.56 60.30 Pre-Feasibility Report Page | 35 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Output 1. 2. 3. Trityl Candesartan Methylene Dichloride (Recovered) Methylene Dichloride (Loss) 4. Ethyl Acetate (Recovered) 5. Ethyl Acetate (Loss) 6. Effluent 7. OrganicResidue Total Pre-Feasibility Report Page | 36 134.0 1.000 370.0 2.761 15.0 0.112 620.0 4.627 40.0 0.299 154.5 1.153 13.6 0.102 1,347.2 10.1 Finished Product Solvent 16.56 Recovered 6.00 0.66 Solvent Loss Solvent Recovered 1.79 Solvent Loss 27.76 6.92 To ETP Organic H/W 0.610 (CHWIF) 60.30 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 5. VALSARTAN a) Manufacturing Process Stage-1: 2-Cyano-4-bromomethyl biphenyl undergoes condensation with L-Valine methyl ester Hydrochloride in presence of Potassium Carbonate and Hydrochloric acid in Dimethylformamide solvent medium to yield stage-1 compound. Stage-2: Stage-1 compound undergoes basification reaction with Sodium Bicarbonate and on further coupling with Valeryl Chloride in presence of Hydrochloric acid, Sodium Sulfate and Triethylamine in o-Xylene solvent media. Stage-3: Charge Stage-2 compound in dil. HCl solution and charge sodium azide solution in water slowly at room temperature. Stir the reaction mass for 3-4 hours and upon completion of reaction extract with methylene dichloride and wash organic layer with dilute sodium hydroxide followed by brine wash and dry organic layer over sodium sulfate. Concentrate organic layer under vacuum to obtain Valsartan. Pre-Feasibility Report Page | 37 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. b) Reaction Chemistry Stage - 1 Reaction Chemistry K2CO3 2-Cyano-4Chemical bromomethyl Name biphenyl Gram/Mole 272 L-Valine Potassium methyl ester Carbonate Hydrochloride 167.5 138 HCl Hydro Chloric Acid 36.5 KCl Stage-I Compound KBr H2O Potassium Potassium Carbon Water Chloride Bromide Dioxide 358.5 74.5 119 18 Stage - 2 Reaction Chemistry Chemical Name Gram/Mole 2 NaHCO3 Page | 38 2 NaCl 2 H2O 2 CO2 Stage-I Compound Valeryl Chloride Sodium Bicarbonate Stage-II Compound Sodium Chloride Water Carbon Dioxide 358.5 120.5 168 406 117 36 88 Pre-Feasibility Report CO2 44 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Stage - 3 Reaction Chemistry Chemical Name Gram/Mole HCl Stage-II Compound 406 2 H2O Hydrochloric Water Acid 36.5 36 NaN3 NaCl H2O CH3OH Sodium Azide Valsartan Sodium Chloride Water Methanol 65 435 58.5 18 32 Pre-Feasibility Report Page | 39 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. c) Process Flow Diagram 2-Cyano-4bromomethyl : biphenyl 85 L-Valine methyl : ester Hydrochloride 68 Potassium Carbonate Hydrochloric acid (35%) Dimethyl formamide (Fresh) Dimethyl formamide (Recovered) Toluene (Fresh) Toluene (Recovered) Water : 67 : 68 : 30 : Product (Stage-1) : Stage 1 Dimethyl formamide : (Recovered) Dimethyl : formamide Loss Toluene : (Recovered) 93 470 20 320 Toluene Loss : 14 470 Effluent : 999 : 20 Organic Residue : 41 : 320 21 : 850 Process Emissions : (CO2) Total : 1,978 Total : 1,978 Product (Stage-1) : 93 Sodium Bicarbonate : 60 Product (Stage-2) : 102 Valeryl Chloride : 40 o-Xylene : (Recovered) 188 Hydrochloric acid : (35%) 58 o-Xylene Loss : 22.5 Methylene Dichloride : 340.5 (Recovered) Methylene : 8 Dichloride Loss Sodium Sulfate : 37 Triethylamide : 33 o-Xylene (Fresh) : 12 Effluent : 823 : 188 Organic Residue : 22 : 29.5 Inorganic Solid : Waste 37 Process Emissions : (CO2) 28 o-Xylene (Recovered) Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) Water : 340.5 : 680 Total : 1,571 Pre-Feasibility Report Page | 40 Stage 2 Total : 1,571 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Product (Stage-2) : Tri-n-Butyl : Tinchloride Sodium Azide : 102 Sodium Hydroxide : 5 Sodium Chloride : 10 Sodium Sulfate : 20 Hydrochloric acid : (35%) 41 o-Xylene (Fresh) o-Xylene (Recovered) Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) Water 173 Valsartan : 100 20 : 6 o-Xylene (Recovered) o-Xylene Loss Methylene Dichloride (Recovered) Methylene Dichloride Loss Effluent : 1329 : 94 Organic Residue : 192 : 32 Inorganic Solid : Waste 20 : 368 : 1260 Stage 3 : 94 : 4 : 368 : 24 Total : 2,131 Total : 2,131 Gross Input : 5,680 Gross Output : 5,680 d) Summary of Mass Balance Capacity, TPM 5.00 Batch size, Kg 100 Working Days 26 Stage - 1 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. 2. 2-Cyano-4-bromomethyl biphenyl L-Valine methyl ester Hydrochloride 85.0 0.850 4.25 Reactant 68.0 0.680 3.40 Reactant Pre-Feasibility Report Page | 41 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 3. Potassium Carbonate 67.0 0.670 3.35 Reactant 4. Hydrochloric acid (35%) Dimethylformamide (Fresh) Dimethylformamide (Recovered) 68.0 0.680 3.40 Reactant 30.0 0.300 1.50 Solvent 470.0 4.700 20.0 0.200 5. 6. 23.50 Solvent Recovered 7. Toluene (Fresh) 8. Toluene (Recovered) 320.0 3.200 16.00 Solvent Recovered 9. Water 850.0 8.500 42.50 1,978.0 19.780 98.90 93.0 0.930 4.65 Used in Next Stage 470.0 4.700 23.50 Solvent Recovered 20.0 0.200 320.0 3.200 14.0 0.140 999.1 9.991 40.7 0.407 2.03 Organic HW (CHWIF) 21.2 0.212 1.06 Atmos. Loss 1,978.0 19.780 Total 1.00 Solvent Output 4. Product (Stage-1) Dimethylformamide (Recovered) Dimethylformamide Loss Toluene (Recovered) 5. Toluene Loss 6. Effluent 7. Organic Residue Process Emissions (CO2) 1. 2. 3. 8. Total 1.00 Solvent Loss 16.00 Solvent Recovered 0.70 Solvent Loss 49.96 To ETP 98.90 Stage - 2 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. Product (Stage-1) 93.0 0.930 4.65 Reactant 2. Sodium Bicarbonate 60.0 0.600 3.00 Reactant 3. Valeryl Chloride Hydrochloric acid (35%) 40.0 0.400 2.00 Reactant 58.0 0.580 2.90 Reactant 5. Sodium Sulfate 37.0 0.370 1.83 To remove water 6. Triethylamide 33.0 0.330 1.65 Reagent 7. o-Xylene (Fresh) 12.0 0.120 0.60 Solvent 4. Pre-Feasibility Report Page | 42 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 8. 9. 10. 11. o-Xylene (Recovered) Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) Water Total 188.0 1.880 9.40 Solvent Recovered 29.5 0.295 1.47 Solvent 340.5 3.405 17.02 Solvent Recovered 680.0 6.800 34.00 1,571.0 15.710 78.53 Output 1. Product (Stage-2) 102.0 1.020 5.10 Used in Next Stage 2. o-Xylene (Recovered) 188.0 1.880 9.40 Solvent Recovered 3. 22.5 0.225 1.12 Solvent Loss 340.5 3.405 8.0 0.080 6. o-Xylene Loss Methylene Dichloride (Recovered) Methylene Dichloride Loss Effluent 823.1 8.231 7. Organic Residue 22.0 0.220 1.10 Organic HW (CHWIF) 8. Inorganic Solid Waste Process Emissions (CO2) Total 37.0 0.370 1.85 Inorganic HW (TSDF) 27.9 0.279 1.39 Atmos. Loss 1,571.0 15.710 4. 5. 9. 17.02 Solvent Recovered 0.40 Solvent Loss 41.15 To ETP 78.53 Stage - 3 Sr. No. Quantity Name of Raw Material Kg/Batch Kg/Kg of Product TPM Remarks Input 102.0 173.0 20.0 5.0 1.020 1.730 0.200 0.050 5.10 8.65 1.00 0.25 Reactant Reactant Reactant Reagent For work up 4. Product (Stage-2) Tri-n-Butyl Tinchloride Sodium Azide Sodium Hydroxide 5. Sodium Chloride 10.0 0.100 0.50 6. Sodium Sulfate 20.0 0.200 1.00 To remove water 7. Hydrochloric acid (35%) 41.0 0.410 2.05 Reactant 8. o-Xylene (Fresh) 6.0 0.060 0.30 Solvent 9. o-Xylene (Recovered) Methylene Dichloride (Fresh) Methylene Dichloride 94.0 0.940 4.70 Solvent Recovered 32.0 0.320 1.60 Solvent 368.0 3.680 1. 2. 3. 10. 11. 18.40 Solvent Recovered Pre-Feasibility Report Page | 43 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. (Recovered) 12. Water Total 1,260.0 12.600 63.00 2,131.0 21.310 106.55 100.0 1.000 5.00 Finished Product Output 1. Valsartan 2. o-Xylene (Recovered) 94.0 0.940 4.70 Solvent Recovered 3. 4.0 0.040 0.20 Solvent Loss 368.0 3.680 24.0 0.240 1.20 Solvent Loss 6. o-Xylene Loss Methylene Dichloride (Recovered) Methylene Dichloride Loss Effluent 1,328.7 13.287 7. Organic Residue 192.3 1.923 8. Inorganic Solid Waste 20.0 0.200 66.43 To ETP Organic HW 9.62 (CHWIF) Inorganic HW 1.00 (TSDF) 2,131.0 21.310 4. 5. Total Pre-Feasibility Report Page | 44 18.40 Solvent Recovered 106.55 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 6. PRANLUKAST a) Manufacturing Process Stage-1: To a stirred solution of Dimethyl Formamide and Methylene dichloride is added 4-(4-phenylbutoxy)benzoic acid. Charge dropwisethionyl chloride. After completion, distill out Methylene Dichloride under vacuum. Charge this reaction mass to stirred solution of 3-amino 2-hydroxy acetophenone in Methylene dichloride and pyridine at 0-5 oC. After completion of reaction, charge Hydrochloric acid and separate layers. Wash with Sodium bicarbonate solution and evaporate organic layer to yield N-(2-hydroxy-3- (3-oxo-3-(1H-tetrazol-5-yl) propanoyl)phenyl)- 4 - (4phenylbutoxy) benzamide Stage-2: N-(2-hydroxy- 3- (3-oxo- 3-(1H-tetrazol-5-yl) propanoyl) phenyl)-4-(4phenylbutoxy) benzamide and sulfuric acid were charged in reactor. Reaction mass was heated at 80 oC for 2-3 hours. After completion, reaction mass was quenched in ice water to yield crude product. Stage-3: Pranlukast (crude) and ethyl acetate were charged in reactor and refluxed for 1 hour. Upon cooling at 10 oC. Solid slurry was filtered to obtain pure product. Pre-Feasibility Report Page | 45 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. b) Reaction Chemistry Stage - 1 Reaction Chemistry Chemical Name SOCl2 4-(4-phenylbutoxy) benzoic acid 1-(3-amino-2hydroxyphenyl) ethanone Thionyl Chloride 271 151 118 Gram/Mole N-(3-acetyl-2hydroxyphenyl)-4-(4phenylbutoxy) benzamide 403 HCl SO2 Hydro chloric Acid Sulphur Dioxide 73 64 Stage - 2 Reaction Chemistry Chemical Name Gram/Mole H2SO4 N-(3-acetyl-2hydroxyphenyl)-4-(4phenylbutoxy) benzamide 403 Pre-Feasibility Report Page | 46 H2SO4 H2O Sulfuric Acid Pranlukast (Crude) Sulfuric Acid Water 98 385 98 18 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Stage - 3 Reaction Chemistry Chemical Name Gram/Mole Pranlukast (Crude) Pranlukast (Pure) 385 385 Pre-Feasibility Report Page | 47 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. c) Process Flow Diagram 4-(4-phenylbutoxy) : benzoic acid 1-(3-amino-2hydroxyphenyl) : ethanone Methylene : Dichloride (Fresh) Methylene Dichloride : (Recovered) Dimethyl : Formamide Thionyl Chloride : 100 57 N-(3-acetyl-2hydroxyphenyl)-4: (4-phenylbutoxy) benzamide 18 125 59 Methylene Dichloride : (Recovered) Methylene : Dichloride (Loss) Effluent : Pyridine : 90 Organic Residue : 27 Hydrochloric acid : Sodium : Bicarbonate Water : 300 Process : Emissions (SO2) 20 Total : 1,529 Pranlukast (Crude) : 106 Effluent : 1562 1062 Organic Residue : 19 Total : 1,687 Total : 1,687 Pranlukast (Pure) : 100 570 5 Stage 1 30 Sulfuric Acid : Water : Intermediate from : Stage 2 Ethyl Acetate : (Fresh) 18 769 300 Total : 1,529 Intermediate from : Stage 1 570 125 500 Stage 2 106 37 Stage 3 Ethyl Acetate : (Recovered) Ethyl Acetate : (Loss) 862 22 Effluent : 15 Organic Residue : 6 Total : 1,005 Total : 1,005 Gross Input : 4,221 Gross Output : 4,221 Ethyl Acetate : (Recovered) 862 d) Summary of Mass Balance Pre-Feasibility Report Page | 48 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Capacity TPM 5.00 Batch size Kg 100 Working Days 26 Stage - 1 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 4-(4-phenylbutoxy) benzoic acid 1-(3-amino-2hydroxyphenyl) ethanone Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) Dimethyl Formamide Thionyl Chloride Pyridine Hydrochloric acid Sodium Bicarbonate Water Total Output N-(3-acetyl-2hydroxyphenyl)-4-(41. phenylbutoxy)benzami de Methylene Dichloride 2. (Recovered) Methylene Dichloride 3. (Loss) 4. Effluent 5. 6. OrganicResidue Process Emissions (SO2) Total 100.0 1.000 5.00 Reactant 57.6 0.576 2.88 Reactant 18.0 0.180 0.90 Solvent 570.0 5.700 5.0 0.050 59.0 89.6 300.0 30.0 300.0 0.590 0.896 3.000 0.300 3.000 2.95 4.48 15.00 1.50 15.00 1,529.2 15.3 76.5 125.0 1.250 6.25 Used in Next Stage 570.0 5.700 28.50 Solvent Recovered 18.0 0.180 769.3 7.693 27.1 0.271 1.35 Organic H/W (CHWIF) 19.8 0.198 0.99 To APCM 1,529.2 15.3 28.50 Solvent Recovered 0.25 Catalyst Reactant Reagent For work up For Neutralization 0.90 Solvent Loss 38.46 To ETP 45.9 Pre-Feasibility Report Page | 49 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Stage 2 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 2. N-(3-acetyl-2hydroxyphenyl)-4-(4phenylbutoxy) benzamide Sulfuric Acid 3. Water 1. Total 125.0 1.250 6.25 Reactant 500.0 5.000 25.00 Reactant 1062.0 10.620 53.10 1,687.0 16.870 84.35 106.3 1.063 1562.0 15.620 18.8 0.188 1,687.0 16.870 Output 1. Pranlukast (Crude) 2. Effluent 3. Organic Residue Total 5.31 Used in Next Stage 78.10 To ETP 0.94 Organic HW (CHWIF) 84.35 Stage 3 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. 2. 3. Pranlukast (Crude) Ethyl Acetate (Fresh) Ethyl Acetate (Recovered) Total 106.3 1.063 5.31 Reactant 37.5 0.375 1.87 862.5 8.625 1,006.3 10.063 100.0 1.000 5.00 Finished Product 862.5 8.625 43.12 Solvent Recovered 22.5 15.0 6.3 1,006.3 0.225 0.150 0.063 10.063 Solvent 43.12 Solvent Recovered 50.30 Output 1. 2. 3. 4. 5. Pranlukast Ethyl Acetate (Recovered) Ethyl Acetate (Loss) Effluent Organic Residue Total 7. TICAGRELOR Pre-Feasibility Report Page | 50 1.12 Solvent Loss 0.75 To ETP 0.31 Organic HW (CHWIF) 50.30 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. a) Manufacturing Process Stage-1: 2 - (((3aR,4S,6R,6aS) - 6 - (7-(((1R,2S) – 2 - (3,4-difluorophenyl) cyclopropyl) amino) – 5 - (propylthio) - 3H - [1,2,3] triazolo [4,5-d] pyrimidin-3-yl) - 2,2dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol and methanol were charged in reactor. 50% solution of Hydrochloric acid was added to reaction mass. Reaction mass was stirred at Room Temperature for 3-4 hours. After completion, reaction mass was quenched in water and extracted with Ethyl Acetate, upon evaporation of which yielded product (Ticagrelor). Stage-2: Ticagrelor and Ethyl Acetate were charged in reactor and heated at 60 oC for 1 hour. Upon cooling at 50 oC and addition of Heptane to the reaction mass yielded pure Ticagrelor. Pre-Feasibility Report Page | 51 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. b) Reaction Chemistry Stage - 1 Reaction Chemistry Chemical Name Gram/Mole 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4difulorophenyl)cyclopropyl)amino)-5(propylthio)-3H-[1,2,3]triazolo[4,5d]pyrimidin-3-yl)-2,2-dimethyltetrahydro3aH-cyclopenta[d][1,3]dioxol-4yl)ody)ethanol 562 H2O HCl Water Hydro Chloric Acid 18 36.5 Reaction Chemistry Chemical Name Gram/Mole Pre-Feasibility Report Page | 52 HCl Ticagrelor (Crude) Aceton 522 58 Hydro Chloric Acid 36.5 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Stage – 2 Reaction Chemistry Ethyl Acetate Heptane Chemical Name Gram/Mole Ticagrelor (crude) Ticagrelor 522 522 c) Process Flow Diagram 2-(((3aR,4S,6R,6aS)-6-(7(((1R,2S)-2-(3,4difluorophenyl)cyclopropyl ) amino)-5-(propylthio)-3H[1,2,3]triazolo[4,5d]pyrimidin-3-yl)-2,2dimethyltetrahydro-3aHcyclopenta[d][1,3]dioxol-4yl)oxy)ethanol Methanol : 57 Stage 1 : 283 Hydrochloric Acid : 141 Ethyl Acetate (Fresh) : 5 Ethyl Acetate (Recovered) : 107 Water : 254 Total : 847 Ticagrelor (Crude) Ethyl Acetate (Recovered) Ethyl Acetate (Loss) Effluent : 51 : 107 : 6 : 679 OrganicResidue : 4 Total : 847 Pre-Feasibility Report Page | 53 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Intermediate from stage 1 : 51 Ethyl Acetate (Fresh) : 14 Ethyl Acetate (Recovered) : 269 Heptane (Fresh) : 12 Heptane (Recovered) : 271 Total : Gross Input : Ticagrelor : (Pure) Ethyl Acetate : (Recovered) Ethyl Acetate (Loss) Heptane (Recovered) Heptane (Loss) Organic Residue 50 269 : 14 : 271 : 12 : 1 617 Total : 617 1,464 Gross Output : 1,464 Stage 2 d) Summary of Mass Balance Capacity, TPM 5.00 Batch size, Kg 50 Working Days 26 Stage 1 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. 2-(((3aR,4S,6R,6aS)-6-(7(((1R,2S)-2-(3,4difluorophenyl)cyclopropyl )amino)-5-(propylthio)-3H[1,2,3]triazolo[4,5d]pyrimidin-3-yl)-2,2dimethyltetrahydro-3aHcyclopenta[d][1,3]dioxol-4yl)oxy)ethanol 2. 56.6 1.132 5.66 Reactant Methanol 282.8 5.656 28.28 Reactant 3. Hydrochloric Acid 141.4 2.828 14.14 Reactant 4. Ethyl Acetate (Fresh) 5.0 0.100 0.50 Solvent 5. Ethyl Acetate (Recovered) 107.5 2.150 10.75 Solvent Recovered 6. Water 254.5 5.090 25.45 Pre-Feasibility Report Page | 54 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Total 84.78 847.8 16.956 51.5 1.030 5.15 Used in Next Stage 107.5 2.150 10.75 Solvent Recovered 5.7 0.114 0.57 Solvent Loss 679.3 13.586 3.8 0.076 847.8 16.956 67.93 To ETP Organic H/W 0.38 (CHWIF) 84.78 Output 1. Ticagrelor (Crude) 2. Ethyl Acetate (Recovered) 3. Ethyl Acetate (Loss) 4. Effluent 5. Organic Residue Total Stage 2 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. Ticagrelor (Crude) 51.5 1.029 5.14 Reactant 2. Ethyl Acetate (Fresh) 14.0 0.280 3. Ethyl Acetate (Recovered) 269.0 5.380 4. Heptane (Fresh) 12.0 0.240 5. Heptane (Recovered) 271.0 5.420 617.5 12.349 1.40 Solvent Solvent 26.90 Recovered 1.20 Solvent Solvent 27.10 Recovered 61.74 50.0 1.000 5.00 269.0 5.380 26.90 14.0 0.280 1.40 271.0 5.420 27.10 12.0 0.240 1.20 1.5 0.029 0.14 617.5 12.349 61.74 Total Output 1. Ticagrelor 2. Ethyl Acetate (Recovered) 3. Ethyl Acetate (Loss) 4. Heptane (Recovered) 5. Heptane (Loss) 6. Organic Residue Total Finished product Solvent Recovered Solvent Loss Solvent Recovered Solvent Loss Organic HW (CHWIF) Pre-Feasibility Report Page | 55 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 8. BAZEDOXIFENE ACETATE a) Manufacturing Process Stage-1: Charge Denatured Spirit, Glacial Acetic acid, 4-Benzyloxy Phenyl Hydrazine Hydrochloride and 4-Benzyloxy propiophenone. Heat to 75-80 oC. After completion cool reaction mass to 10-15 oC. Filter slurry to obtain 3-Methyl-5-(Phenylmethoxy)-2[(4-Phenylmethoxy] Phenyl]-1H Indole. Stage-2: Charge 4-Hydroxy Benzyl Chloride, Sodium Hydroxide and water. Stir for 30 minutes and charge toluene. Add 2-Chloro Ethyl Azepan Hydrochloride and Tetra Butyl Ammonium Bromide and heat to reflux. Upon completion of reaction cool to room temperature and separate organic layer. Distill out toluene and charge Methylene Dichloride. Pass Hydrochloride gas for 1.5 hour. Distill out Methylene and add acetone. Cool reaction mass to 0 oC for 5 hours. Filter slurry to obtain 4-[2-(1Azepanyl)Ethoxy] BenzylAlcohol Hydrochloride. Stage-3: Charge Dimethyl Formamide, 3-Methyl-5-(Phenylmethoxy)-2-[(4- Phenylmethoxy] Phenyl]-1H Indoleand Sodium Methoxide. Heat to 50-55 oC for 2 hours and cool to room temperature. Charge 4-[2-(1-Azepanyl)Ethoxy] Benzylchloride Hydrochlorideand stir. Upon completion of reaction, distill Dimethyl Formamide below 60 oC. Charge water and ethyl acetate to separate layers. Evaporate Organic layer under vacuum. Charge Ethyl Alcohol to the reaction mass and stir for 1 hour. Filter solids. Charge Ethyl acetate to the wet cake. Charge Palladium Charcoal. Stir for 4-5 hours at 45-50 oC. Filter reaction mass and distill Ethyl acetate under vacuum. Charge Ethanol and adjust pH to 2 using Hydrochloric acid. Filter the solids. Charge Ethyl acetate to the wet cake. Charge Sodium bicarbonate solution and heat to 50 oC. Separate organic layer and add charcoal. Stir and filter. Distill out Ethyl acetate. Charge Acetone and L-Ascorbic acid to the reaction mass. Heat 40-45 oC. Charge Glacial acetic acid and cool to room temperature and filter slurry to obtain Bazedoxifene Acetate. Pre-Feasibility Report Page | 56 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. b) Reaction Chemistry Stage - 1 Reaction Chemistry Chemical Name Gram/Mole H2O NH3 HCl 4-Benzyloxyphenyl Hydrazine Hydrochloride 1-(4-(benzyloxy)phenyl) propane-1-one 5-(benzyloxy)-2-(4(benzyloxy)phenyl)-3methyl-1 H-indole Water Ammonia Hydrochloric Acid 250.72 240.3 419.51 18 17 36.5 Stage - 2 Reaction Chemistry Chemical Name Gram/Mole 2NaOH HCl 2NaCl 2H2O (4-(chloromethyl)phenyl) methanol 1-(2-Chloroethyl) azepane hydrochloride Sodium Hydroxide Hydro Chloric Acid 1-(2-((4-(chloromethyl) benzyl)oxy) ethyl) azepane hydrochloride Sodium Chloride Water 156.61 198.13 80 36.5 318.28 117 36 Stage - 3 Reaction Chemistry Chemical Name Gram/Mole 2NaOMe 5-(benzyloxy)-2-(4(benzyloxy)phenyl)-3methyl-1 H-indole 419.51 1-(2-((4Sodium (chloromethyl)benzyl)oxy) Methoxide ethyl)azepanehydrochloride 318.28 108 Pre-Feasibility Report Page | 57 CH3COOH 2H2 2NaCl Acetic Acid Hydrogen Benzedoxifene Acetate Toluene 60 4 530.65 184 2MeOH Sodium Methanol Chloride 117 64 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. c) Process Flow Diagram 4-Benzyloxyphenyl Hydrazine Hydrochloride 1-(4(benzenyloxy)phenyl) propan-1-one Denatured Spirit (Fresh) Denatured Spirit (Recovered) Glacial Acetic acid : 20 : 19.2 : 8 : 232 : Water : Total (4-(chloromethyl) phenyl) : methanol 2-Chloro Ethyl : Azipan hydrochloride 5-(benzyloxy)-2-(4(benzyloxy)phenyl)- : 3-methyl-1H-indole 32 0.2 Denatured Spirit : (Recovered) Denatured Spirit : (Loss) Effluent : 105.6 100 OrganicResidue : 1.8 Stage 1 232 8 379.4 Total 379.4 11 1-(2-((4 (chloromethyl)benzyl) oxy) ethyl) azepane hydrochloride 23.7 21 : Sodium Hydroxide : 8 Toluene (Recovered) : 86 Tetra Butyl : Ammonium Bromide 0.5 Toluene (Loss) : 4 Toluene (Fresh) : 4 Toluene (Recovered) : 86 Methylene Dichloride (Fresh) Methylene Dichloride (Recovered) Hydrochloric acid Gas Acetone (Fresh) Stage 2 Methylene Dichloride : (Recovered) Methylene Dichloride : (Loss) 245 15 : 15 Acetone (Recovered) : 215 : 245 Acetone (Loss) : 9 : 35 Effluent : 200 : 9 Acetone (Recovered) : 215 Organic Residue : 1.8 Water : 150 Total : 799.5 Total : 799.5 Pre-Feasibility Report Page | 58 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Intermediate from : Stage 1 Intermediate from : Stage 2 Sodium Methoxide : 23.7 Palladium Carbon : 9 Dimethyl Formamide (Fresh) Dimethyl Formamide (Recovered) Ethyl Acetate (Fresh) Ethyl Acetate (Recovered) Ethyl Alcohol (Fresh) Ethyl Alcohol (Recovered) L-Ascorbic Acid 32 8.4 : 10 : 440 : 50 : Bazedoxifene : Acetate Dimethyl Formamide : (Recovered) 36 440 Dimethyl Formamide : (Loss) 10 Ethyl Acetate : (Recovered) 550 550 Ethyl Acetate (Loss) : 50 : 15 Ethyl Alcohol : (Recovered) 345 : 345 Ethyl Alcohol (Loss) : 15 : 0.3 Effluent : 438.6 Carbon : 3 Organic Residue : 5 Hydrochloric acid : 10 Glacial Acetic acid : 5 Inorganic Residue : 12 Water : 400 Hydrogen Gas : 0.15 Stage 3 Total : 1,901.6 Total : 1,901.6 Gross Input : 3,080.5 Gross Output : 3,080.5 Pre-Feasibility Report Page | 59 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. d) Summary of Mass Balance Capacity, TPM 5.00 Batch size, Kg 36 Working Days 26 Stage - 1 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 5. 4-Benzyloxyphenyl Hydrazine Hydrochloride 1-(4-(benzenyloxy) phenyl) propan-1one Denatured Spirit (Fresh) Denatured Spirit (Recovered) Glacial Acetic acid 6. Water 1. 2. 3. 4. Total Output 5-(benzyloxy)-2-(41. (benzyloxy)phenyl)3-methyl-1H-indole Denatured Spirit 2. (Recovered) Denatured Spirit 3. (Loss) 4. Effluent 5. Organic Residue Total 20.0 0.556 2.78 Reactant 19.2 0.533 2.67 Reactant 8.0 0.222 1.11 Solvent 232.0 6.444 0.2 0.006 100.0 2.778 13.89 379.4 10.539 52.70 32.0 0.889 4.44 Used in 3rd Stage 232.0 6.444 32.22 Solvent Recovered 8.0 0.222 105.6 2.934 1.8 0.049 379.4 10.539 32.22 Solvent Recovered 0.03 Reactant 1.11 Solvent Loss 14.67 To ETP 0.26 Organic H/W (CHWIF) 52.70 Stage - 2 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 1. 2. (4-(chloromethyl) phenyl)methanol 2-Chloro Ethyl Pre-Feasibility Report Page | 60 11.4 0.316 1.58 Reactant 20.7 0.576 2.88 Reactant Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Azipan hydrochloride 3. Sodium Hydroxide Tetra Butyl 4. Ammonium Bromide 5. Toluene (Fresh) Toluene 6. (Recovered) Methylene 7. Dichloride (Fresh) Methylene 8. Dichloride (Recovered) Hydrochloric acid 9. Gas 10. Acetone (Fresh) Acetone 11. (Recovered) 12. Water Total Output 1-(2-((4(chloromethyl)benzy 1. l)oxy)ethyl) azepane hydrochloride Toluene 2. (Recovered) 3. Toluene (Loss) Methylene 4. Dichloride (Recovered) Methylene 5. Dichloride (Loss) Acetone 6. (Recovered) 7. Acetone (Loss) 8. Effluent 9. Organic Residue Total 7.7 0.215 1.07 Reactant 0.5 0.014 0.07 Reactant 4.0 0.111 0.56 Solvent 86.0 2.389 15.0 0.417 245.0 6.806 35.0 0.972 4.86 9.0 0.250 1.25 Solvent 215.0 5.972 29.86 Solvent Recovered 150.0 4.167 20.83 799.4 11.94 Solvent Recovered 2.08 Solvent 34.03 Solvent Recovered 22.204 111.01 23.7 0.658 3.29 Used in 3RD Stage 86.0 2.389 11.94 Solvent Recovered 4.0 0.111 245.0 6.806 15.0 0.417 215.0 5.972 9.0 0.250 199.9 5.551 1.8 0.051 799.4 0.55 Solvent Loss 34.03 Solvent Recovered 2.08 Solvent Loss 29.85 Solvent Recovered 1.25 Solvent Loss 27.75 To ETP 0.26 Organic HW (CHWIF) 22.204 111.01 Pre-Feasibility Report Page | 61 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Stage - 3 Sr. No. Name of Raw Material Quantity Kg/Kg Kg/Batch of Product TPM Remarks Input 3. 5-(benzyloxy)-2-(4(benzyloxy)phenyl)-3methyl-1H-indole 1-(2-((4(chloromethyl)benzyl) oxy)ethyl) azepane hydrochloride Sodium Methoxide 4. Glacial Acetic acid 5. 8. Hydrogen Gas Dimethyl Formamide (Fresh) Dimethyl Formamide (Recovered) Ethyl Acetate (Fresh) 9. Ethyl Acetate (Recovered) 10. Ethyl Alcohol (Fresh) 11. Ethyl Alcohol (Recovered) 12. Palladium Carbon 9.0 0.250 1.25 Catalyst 13. L-Ascorbic Acid 0.3 0.008 0.04 Catalyst 14. Carbon 3.0 0.083 0.42 Decolorize 15. Hydrochloric acid 10.0 0.278 1.39 Neutralization 16. Water 400.0 11.111 55.56 1,901.4 52.814 264.08 1. 2. 6. 7. Total 32.0 0.889 4.44 Intermediate product from stage- 1 23.7 0.658 3.29 Intermediate product from stage- 2 8.4 0.233 1.17 Reactant 4.8 0.133 0.67 Reactant 0.15 0.004 0.02 Reactant 10.0 0.278 1.39 Solvent 440.0 12.222 50.0 1.389 550.0 15.278 15.0 0.417 345.0 9.583 61.11 Solvent Recovered 6.94 Solvent 76.39 Solvent Recovered 2.08 Solvent 47.92 Solvent Recovered Output 36.0 1.000 5.000 Finished Product 440.0 12.222 61.11 Solvent Recovered 3. Bazedoxifene Acetate Dimethyl Formamide (Recovered) Dimethyl Formamide (Loss) 10.0 0.278 4. Ethyl Acetate (Recovered) 550.0 15.278 5. Ethyl Acetate (Loss) 50.0 1.389 6. Ethyl Alcohol (Recovered) 345.0 9.583 7. Ethyl Alcohol (Loss) 15.0 0.417 8. Effluent 438.6 12.184 9. Organic Residue 4.7 0.131 1. 2. Pre-Feasibility Report Page | 62 1.39 Solvent Loss 76.39 Solvent Recovered 6.94 Solvent Loss 47.92 Solvent Recovered 2.08 Solvent Loss 60.92 To ETP 0.66 Organic HW Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. (CHWIF) 10. Inorganic Residue Total 12.0 0.332 1.67 1,901.4 52.814 264.08 Inorganic HW (TSDF) Pre-Feasibility Report Page | 63 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 4.5 Raw Material Requirements Various raw materials will be required for manufacturing of proposed products. Details of raw material requirement for proposed project are given below in Table-8. Table - 8: Details of Raw Material Requirements Requirement Sr. No. 1 2 3 4 5 6 7 8 9 10 11 Name of Raw Material [2(((3aR,4S,6R,6aS)-6(7-(((1R,2S)-2-(3,4difluorophenyl) cyclopropyl)amino)-5(propylthio)- 3H[1,2,3]triazolo[4,5d]pyrimidin-3-yl)-2,2dimethyltetrahydro3aH-cyclopenta[d] [1,3]dioxol-4-yl)oxy) ethanol] 2-(2-(phenylthio)-5propionylphenyl) acetic acid 2-Chloro Ethyl Azipan hydrochloride 2-Cyano-4bromomethyl biphenyl 1-(3-amino-2hydroxyphenyl) ethanone 4-(4phenylbutoxy)benzoic acid 4-(tert-Butyl)benzene1-sulfonamide 1-(4(benzenyloxy)phenyl) propan-1-one 4-Benzyloxyphenyl Hydrazine Hydrochloride 4-bromo-3-oxo-Nphenylbutanamide 4-chloro benzoyl chloride Pre-Feasibility Report Page | 64 Product Code Kg/Kg of Product TPM Total Max of Requirement Group (TPM) (TPM) 7 1.131 5.66 5.66 5.66 3 1.414 8.48 8.48 8.48 8 0.576 2.88 2.88 2.88 5 0.850 4.25 4.25 4.25 6 0.576 2.88 2.88 2.88 6 1.000 5.00 5.00 5.00 1 0.510 3.06 3.06 3.06 8 0.533 2.67 2.67 2.67 8 0.556 2.78 2.78 2.78 2 0.764 4.58 4.58 4.58 2 0.575 3.45 3.45 3.45 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 12 13 (4(chloromethyl)phenyl) methanol 5-(2Methoxyphenoxy)4,6-dichloro-2(pyrimidin-2-yl) pyrimidine 8 0.316 5.00 5.00 5.00 1 0.835 5.01 5.01 5.01 2 0.023 0.14 3 0.086 0.52 0.52 0.52 14 Acetic Acid 15 Acetone 8 0.250 1.25 1.25 1.25 16 Bromine 3 0.919 5.52 5.52 5.52 17 Candesartan 4 0.680 4.08 4.08 4.08 18 Carbon 8 0.083 0.42 0.42 0.42 19 Denatured Spirit Diethyl 2aminomalonate Hydrochloride 8 0.222 1.11 1.11 1.11 2 0.694 4.16 4.16 4.16 6 0.050 0.25 8 0.278 1.39 1.5 1.5 5 0.300 1.50 3 0.146 0.88 0.88 8 0.417 2.08 2.08 6 0.375 1.88 7 0.380 1.90 8 1.389 6.94 4 0.299 1.79 1.79 20 21 22 23 Dimethyl Formamide Ethanol Ethyl Acetate 6.94 2.88 8.74 24 Ethylene Dichloride 3 0.152 0.91 0.91 0.91 25 Ethylene glycol 1 0.150 0.90 0.90 0.90 26 Glacial Acetic acid 8 0.139 0.69 0.69 0.69 27 Heptane 7 0.240 1.20 1.20 1.20 2 0.186 1.12 1.12 7 2.828 14.14 8 0.278 1.39 6 3.000 15.00 5 1.670 8.35 8 0.972 4.86 4.86 4.86 8 0.004 0.02 0.02 0.02 28 29 30 Hydrochloric Acid Hydrochloric acid Gas Hydrogen Gas 15.00 16.12 Pre-Feasibility Report Page | 65 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 31 32 33 34 L-Ascorbic Acid L-Valine methyl ester Hydrochloride Methanol Methylene Dichloride (Fresh) 8 0.008 0.04 0.04 0.04 5 0.680 3.40 3.40 3.40 7 5.656 28.28 28.28 2 0.144 0.87 3 0.657 3.94 1 0.335 2.01 2 0.037 0.22 4 0.112 0.67 5 0.615 3.08 6 0.180 0.90 8 0.417 2.08 3.94 32.22 2.01 5.09 3.08 35 o-Xylene (Fresh) 5 0.180 0.90 0.90 0.90 36 Palladium Carbon 8 0.250 1.25 1.25 1.25 37 Polyphosphoric acid 3 5.657 33.94 33.94 33.94 38 Potassium Carbonate 5 0.670 3.35 3.35 3.35 39 Pyridine 6 0.896 4.48 4.48 4.48 40 Sodium Azide 5 0.200 1.00 1.00 1.00 1 0.205 1.23 1.23 5 0.600 3.00 6 0.300 1.50 41 Sodium Bicarbonate 3.00 4.23 42 Sodium Carbonate 3 0.520 3.12 3.12 3.12 43 Sodium Chloride 5 0.100 0.50 0.50 0.50 2 0.256 1.54 3 0.778 4.67 5 0.050 0.25 8 0.215 1.07 1 0.130 0.78 2 0.356 2.14 8 0.233 1.17 1.17 5 0.570 2.85 2.85 3 0.141 0.85 2 0.698 4.19 6 5.000 25.00 25.00 8 0.014 0.07 0.07 44 45 46 47 48 Sodium hydroxide Sodium Methoxide Sodium Sulfate Sulfuric acid Tetra Butyl Ammonium Bromide Pre-Feasibility Report Page | 66 4.67 5.74 1.07 2.14 4.19 3.30 2.85 29.19 0.07 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 49 50 Thionyl Chloride Toluene 6 0.590 2.95 1 0.500 3.00 3 0.303 1.82 5 0.200 1.00 8 0.111 0.56 2 0.722 4.33 4 0.279 1.67 51 Triethyl Amine 52 5 0.330 3 55 Triethylamide Trimethyl Ortho Formate Tri-n-Butyl Tinchloride Trityl Chloride 56 57 53 54 4.6 2.95 2.95 3.00 4.00 1.00 4.33 4.33 1.65 1.65 1.65 1.232 7.39 7.39 7.39 5 1.730 8.65 8.65 8.65 4 0.476 2.86 2.86 2.86 Valeryl Chloride 5 0.400 2.00 2.00 2.00 Zinc Dust 3 0.061 0.36 0.36 0.36 Details of Machineries & Utilities As the proposed project will have different production segments for the manufacturing of various products, this requires various plant machineries and also various utilities will be required. The lists of plant machineries for the proposed project are given in Table-9. However, the actual requirements of machineries & equipment are not limited to the basic list below as some minor requirements can also be cited depending up on necessity noticed during installation & operations. Table – 9: Details of Proposed Machineries and Utilities Sr. No. Item Name 1. Glass lined reactor 2. Glass lined reactor 3. Glass lined reactor 4. Glass lined reactor 5. Stainless steel reactor 6. Stainless steel reactor 7. Stainless steel reactor 8. Stainless steel reactor Make Swiss GlasCoat Swiss GlasCoat Swiss GlasCoat Swiss GlasCoat Nitin Engineering Nitin Engineering Nitin Engineering Nitin Engineering Qty. Size/ Capacity 2 1 4 2 1 3 1 4 1 1 5 2 2 3 2 4 Pre-Feasibility Report Page | 67 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Sr. No. Item Name 9. Tray Dryer 10. Tray Dryer 11. Vacuum Tay Dryer 12. Fluidized bed dryer 13. Fluidized bed dryer 14. Blender 15. Miller 16. Centrifuge 17. Centrifuge 18. Sparkler filter Make Nitin Engineering Nitin Engineering Nitin Engineering Nitin Engineering Nitin Engineering Nitin Engineering Nitin Engineering D Parikh D Parikh Nitin Engineering Qty. Size/ Capacity 1 48 Tray 2 96 Tray 2 48 Tray 2 200 kg 1 160 kg 2 100 kg 1 50 kg/Hr 1 36’’ 7 48’’ 2 18’’a 4.7 Solvent Recovery System: The industry proposes to manufacture synthetic organic chemicals, which require solvents during various unit processes. The spent solvent generated during the manufacturing process will be recovered by way of distillation and reused in the process. The process of the solvent recovery system is described hereunder; After the completion of the reaction, the reaction mass is either directly distilled out through distillation inside the reactor to recover the solvent and separate the product or the mother liquor/solvent from the reactor will be separated and then taken for distillation to recover the solvent and separate the impurities. Firstly, the mass will be distilled at required temperature where pure solvent will be distilled out depending on their boiler points and it will be collected in the recovered solvent storage tank and reused in the process. The recovered solvent will be reused in the process and residue will be sent to TSDF/CHWIF site for the disposal by incineration. Vacuum will also be applied during distillation. The summary of the solvent consumption and mass balance is given in Table - 10. Pre-Feasibility Report Page | 68 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Table - 10: Summary of Solvent Consumption and Mass Balance Sr. No. 1 2 3 Name of Solvent Toluene Methylene Dichloride Dimethyl Formamide Product Code Solvent Requirement, TPM Fresh Recovered 1 3.00 47.10 3 1.82 5 Total Solvent Requirement,% Fresh Recovered Total 50.10 5.99 94.01 100 23.64 25.46 7.14 92.86 100 1.00 16.00 17.00 5.88 94.12 100 8 0.56 11.94 12.50 4.44 95.56 100 1 2.01 23.04 25.05 8.02 91.98 100 2 0.22 3.13 3.35 6.67 93.33 100 4 0.67 16.57 17.24 3.90 96.10 100 5 3.08 35.43 38.50 7.99 92.01 100 6 0.90 28.50 29.40 3.06 96.94 100 8 2.08 34.03 36.11 5.77 94.23 100 5 1.50 23.50 25.00 6.00 94.00 100 8 1.39 61.11 62.50 2.22 97.78 100 4 O-xylene 5 0.90 14.10 15.00 6.00 94.00 100 5 Methanol 2 0.87 32.65 33.52 2.58 97.42 100 3 3.94 46.97 50.91 7.74 92.26 100 2 0.14 3.21 3.35 4.17 95.83 100 3 0.52 4.85 5.36 9.61 90.40 100 6 Acetic Acid 7 Ethylene Dichloride 3 0.91 20.30 21.21 4.29 95.71 100 8 Ethanol 3 0.88 16.06 16.94 5.19 94.81 100 9 Ethyl Acetate 6 1.88 43.13 45.00 4.17 95.83 100 7 1.90 37.65 39.55 4.80 95.20 100 8 6.94 76.39 83.33 8.33 91.67 100 4 1.79 27.76 29.55 6.06 93.94 100 10 Heptane 7 1.20 27.10 28.30 4.24 95.76 100 11 Denatured Spirit 8 1.11 32.22 33.33 3.33 96.67 100 12 Aceton 8 1.25 29.86 31.11 4.02 95.98 100 13 Ethyl Alcohol 8 2.08 47.92 50.00 4.17 95.83 100 44.53 784.15 828.68 5.40 94.60 100 Total/Average Measures for achieving maximum solvent recovery: The entire manufacturing activities & distillation process will be carried out in totally closed system. Pre-Feasibility Report Page | 69 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Maintenance of the pipeline, valves & fittings will be carried out regularly to avoid any leakages. Reactor will be connected with two numbers of condensers where cooling water and chilled water will be used as media and also equipped with vacuum system as per requirement. The condenser will be provided with the sufficient HTA and residence time to achieve 90- 98% recovery. Pre-Feasibility Report Page | 70 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 5. Pollution Potential and Control Measures 5.1 (a) Water Pollution Details of Water Requirement & Wastewater Generation The water requirement for the proposed project will be met by ground water supply through own bore well. The total fresh water requirement for various domestic, gardening & industrial activities will be 8.30 KLD. Based on the material balance and technical experience of the similar industries, the water consumption and wastewater generation for all the products as well as for various categories have been calculated. The fresh water requirement for industrial activities will be 5.3 KLD, which will be mainly used in the process, cooling, and washing activities. The water requirement for domestic activity will be 1.5 KLD and for green belt development will be 1.5 KLD. The product-wise water requirement & wastewater generation is given in Table – 11(a) and category-wise water requirement and wastewater generation is given in Table – 11(b). The water balance diagram is given in Drawing-2. Table – 11(a) Product-wise Water Requirement & Wastewater Generation Group Group A Group B Product Code 1 2 3 4 5 6 7 8 Water Consumption Stream Process Process Process Process Process Process APCE Process & APCE Process Process Liter / Kg of Product KLD Wastewater Generation Liter / Kg KLD of Product 8.35 6.28 19.28 0.82 27.90 13.62 1.05 1.93 1.45 4.45 0.19 5.37 2.62 0.20 8.76 8.85 28.21 1.15 31.51 23.46 0.00 2.02 2.04 6.51 0.27 6.06 4.51 0.00 14.67 2.82 23.46 4.51 5.09 18.06 0.98 3.47 13.59 20.67 2.61 3.97 Maximum of Group A 4.45 6.51 Maximum of Group B 5.37 6.06 Total Water Consumption / Generation (KLD) 9.82 12.57 Pre-Feasibility Report Page | 71 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Table – 11(b): Category-wise Water Requirement & Wastewater Generation Sr. No. Particulars Stream Water Requirement, KLD Waste Water Generation, KLD I Domestic Fresh 1.5 1.0 II Gardening Fresh 1.5 Nil III Industrial Fresh 1.8 a Process & APCE b Boiler c Cooling d Washing Total Industrial Water Requirement / Generation Total water Requirement / Generation (I+ II+ III) Reused (from ETP) Reused (from ETP) Fresh (from WTP) Fresh (from WTP) Fresh+ Reuse Reuse from ETP 8.2 13.0 8.0 2.0 2.0 0.1 1.5 1.5 21.5 16.6* 16.2 16.2* Fresh 5.3 Nil Fresh 8.3 1.0 *Note: The difference of 0.4 KL/Day between total industrial wastewater generation (i.e. 16.6 KL/Day) and industrial effluent reuse (i.e. 16.2 KL/Day) is salts generated from MEE during evaporation and it will be disposed of by land filing to TSDF site. Pre-Feasibility Report Page | 72 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Drawing – 2: Water Balance Diagram (1.5) Fresh Water (Source: Bore well) (8.3 = 5.3 + 3.0) Domestic (1.0) To soak pit through septic tank Gardening Nil (1.5) Industrial Fresh: 5.3 Recycled from ETP: 8.2 WTP: 13.5 RO Reject: (3.5) RO Permeate: (10.0) (8.0) (2.0) Process& APCE Cooling (13.0) (1.5) Washing (0.1) (6.0) (7.0) High TDS/COD Stream Low TDS/COD Stream (1.5) (7.0) Boiler (2.0) Industrial Wastewater Generation 16.6 KLD (3.6) (13.0) MEE MEE Condensate (12.6) (0.4) ETP (23.2) Salt to TSDF RO RO Permeate (16.2) RO Reject: 7.0 RO Permeate: 8.2 *All quantities are expressed in KL/Day Pre-Feasibility Report Page | 73 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. (b) Wastewater Management System Effluent generation from industrial activities will be 16.6 KLD. After treatment in ETP followed by RO, treated effluent @16.2 KLD will recycled for Process @ 8.2 KLD and Boiler @ 8.0 KLD purpose. There will be no discharge of treated effluent and therefore, unit will maintain Zero Liquid Discharge. The details of proposed effluent treatment scheme are given in Drawing – 3. Stream wise characteristic of effluent and stage wise characteristic of effluent are given in Table – 12(a) and Table – 12(b) respectively. Proposed Effluent Treatment Scheme Effluent generated from proposed project will be segregated into high concentration and low concentration streams. High concentrated wastewater stream will be treated in proposed Multiple Effect Evaporator after giving physico-chemical treatment. Condensate water from MEE will be sent to ETP along with other waste streams i.e. Process & APCE, Cooling, Washing and Boiler. Raw effluent will be collected in collection cum neutralization tank for proper mixing and neutralization of effluent. Effluent from neutralization tank will be sent to primary tube settler by pumping. Settled sludge will be sent to sludge sump and supernatant effluent will be sent to Moving Bed Bio Reactor (MBBR). Air blowers will be provided for air and oxygen requirement through bubble diffusers. Treated effluent from MBBR will be then sent to secondary settling tube settler for sludge to settle down. Settled sludge will be sent to sludge sump and treated effluent collected in collection tank for further treatment. Treated effluent from collection tank will pass through Pressure sand filter and activated carbon filter to remove remaining solid particles, dead micro organisms and color. Further, treated effluent will be sent to RO unit. RO permeate will be recycled back for use in process and boiler. RO reject will be sent to MEE for further treatment. Pre-Feasibility Report Page | 74 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Drawing - 3: Schematic flow diagram of Proposed Effluent Treatment Plant Pre-Feasibility Report Page | 75 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Table – 12(a): Stream wise Characteristics of Effluent Sr No. W/W Stream Process & APCE Boiler b. Hydraulic Flow 13.00 2.00 Rate, KLD Concentration of Parameters, mg/l 1. pH 2. a. Cooling Washing Composite Ind. Effluent 0.10 1.50 16.60 4.0 – 5.0 6.0 - 7.0 6.5 - 7.5 7.0 - 8.0 5.0 - 6.0 TDS (Max.), mg/L 7,768 1800.0 2000.0 2000.0 6,493 3. COD (Max.), mg/L 5,832 30 40 1,000 4,662 4. BOD (Max.), mg/L 1,868 10.0 15.0 300.0 1,491 Table – 12(b): Stage wise Characteristics of Effluent Sr. No. 1. Parameter pH Composite Influent 5.0 - 6.0 Primary Outlet 6.5 - 8.5 Secondary Outlet 6.5 - 8.5 Tertiary Outlet 6.5 - 8.5 2. TDS (Max.), mg/L 6,493 5,500 5,500 1,000 3. COD (Max.), mg/L 4,662 2,400 500 100 4. BOD (Max.), mg/L 1,491 800 170 30 5.2 Air Pollution The main sources of air pollution will be flue gas emission & process gas emission from the proposed project. There will be also chances of fugitive emission due to manufacturing activities and raw material handling and transportation. Various sources of air pollution are described hereunder; (a) Process Gas Emissions The source of process gas emission from the proposed manufacturing activity will be SO2 gas generated from the manufacturing of product Pranlukast. The details of gaseous pollutants liberated due to proposed manufacturing activities are given in Table - 13 (a) and details of process gas stack are given in Table – 13 (b). The adequate scrubbing system consisting of alkali (Caustic) scrubber will be provided for the control of process gas emission. Output from APCE will be sold as a by-product or will be sent to ETP along with other waste streams. Pre-Feasibility Report Page | 76 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Table – 13(a): Details of Process Gas Emissions Product Code 6 Expected Pollutants Product SO2 Pranlukast Pollution Load Kg/Kg of Product MT/Month MT/Day 0.198 0.99 0.038 Table – 13(b): Details of Process Gas Stack Stack Sr. Height Dia. Polluant attached No. (m) (m) Concentration to 1. Reactors 10 0.10 SO2 ≤ 40 mg/Nm3 APCM Output Mangement Alkali Scrubber Sell as a byproduct or send to ETP for treatment (b) Flue Gas Emissions Main source of flue gas generation will be steam boiler (2 TPH) and Thermic fluid boiler (2 Lac Kcal/hr) from the proposed unit. Biofuel / Agrowaste will be used as a fuel in the boilers & Thermic fluid boiler and individual multi cyclone separator will be provided for the control of emissions. The Unit will also install DG Sets of 250 KVA capacity as stand-by units. Adequate stack height will be provided to ensure proper dispersion of pollutant. The details of flue gas emission are given hereunder in Table 14. Table – 14: Detils of Flue Gas Stacks Sr. Stack Attach to No. Air Pollution Control Mesures Multi Cyclone PM ≤ 150 mg/Nm3 Separator 2.5 Multi SO2 ≤ 100 ppm Cyclone NOx ≤ 50 ppm Separator Adequate 1.2 stack height Fuel Height Dia. Concentration of Requirement (m) (m) Polluants 1 Steam Boiler (2 TPH) 2 Thermic Fluid Boiler (2 Lac Kcal/hr) (80 TPM) 3 DG Set (250 KVA), Stand-by Diesel (125 Lit/Hr) (c) Fugitive Emission Biofuel / Agrowaste 4.0 3.2 There will be a chance of fugitive emission from the manufacturing process as well as due to storage & handling of raw materials and products. The unit will take following adequate precautions for the control of fugitive emission; Pre-Feasibility Report Page | 77 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. The entire manufacturing activities will be carried out in the closed reactors and regular checking and maintenance of reactors will be carried out to avoid any leakages. All the motors of pumps for the handling of hazardous chemicals will be flame proof and provided with suitable mechanical seal with stand-by arrangement. Control of all parameters on a continuous basis will be done by adequate control valves, pressure release valves and safety valves etc. All the flange joints of the pipe lines will be covered with flange guards. All the raw materials will be stored in isolated storage area and containers are tightly closed. Precautionary measures will also be taken while handling various hazardous chemicals. There will also be provision of adequate ventilation system in process plant and hazardous chemical storage area. A regular preventive maintenance will be planned to replace or rectify all gaskets, joints etc. The unit will also develop green belt within the factory premises to control the fugitive emission from spreading into surrounding environment. 5.3 Hazardous Waste Generation and Management The main sources of hazardous waste generation from proposed unit will be dried sludge from ETP and various process waste viz. Inorganic Process waste, Organic Residue, Spent Carbon and Spent Solvent. The ancillary source of hazardous waste generation will be discarded Containers/bags from storage and handling of raw materials and spent/used oil generation from plant & machinery. The details of hazardous waste generation and handling / Management are given in Table-15. Table –15: Hazardous Waste Generation and Management Source ETP Process Type of waste Quantity Physicalper Chemical Annum Form ETP Sludge 34.3 5 MT Solid & Inorganic Inorganic Waste 28.1 35 MT Solid & Inorganic Organic Residue 28.1 211 MT Semisolid & Organic Spent Carbon 28.2 20 MT Solid & Inorganic Pre-Feasibility Report Page | 78 Category Method of Disposal Collection, Storage, Transportation, Disposal by land filling at TSDF Collection, Storage & disposal by land filling at TSDF Collection, Storage, Transportation, Disposal by incineration at CHWIF OR Disposal by co-processing in Cement Kiln Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. Spent Solvent Raw Material Storage & Handling Discarded Containers/ Bags Plant and Spent Oil/ Machineries Used Oil 28.5 275 MT Liquid & Organic Collection, storage & Reuse after distillation within premises 33.3 100 Nos. (10 Kg) Solid & Inorganic Collection, Storage, Decontamination and Disposal by selling to scrap vendors Liquid & Organic Collection, Storage, Transportation, sell to registered Reprocessor / MoEF approved recyclers OR Reused as Lubricant within premises 5.1 50 Lit The unit will provide an adequate designated storage area for the hazardous waste storage within premises having impervious floor, roof cover system and leachate collection system. The hazardous waste will be disposed of through the GPCB approved TSDF / CHWIF sites after obtaining necessary permission. 5.4 Noise & Vibration Control The only source of noise generation may be from the DG Set , which will be kept as stand-by and no other source of noise and vibration in the proposed unit except plant machineries. However, the following adequate precautions will be taken for control of noise & vibration; The unit will install latest technology based low noise DG Set with acoustic enclosures. Proper and timely oiling, lubrication and preventive maintenance will be carried out for the machineries and equipments to reduce noise generation. The noise generation will be mitigated by installing noise barriers/absorbers around stationery noise sources. Adequate noise control measures such as antivibration pad for equipment with high vibration will be provided. All the vibrating parts will be checked periodically and serviced to reduce the noise generation. The equipment, which generates excessive noise, will be provided with enclosures etc. To minimize the adverse effect on the health, ear muffs / earplugs will be provided to the working under high noise area. To reduce the noise generation during the transportation activities; the vehicles will be kept periodically serviced and maintained as per the requirement of latest trend in automobile industry. Only those vehicles with PUC’s will be allowed for the transportation. Pre-Feasibility Report Page | 79 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. The transport contractors will be informed to avoid unnecessary speeding of vehicles inside the premises. Green belt area will be developed to prevent the noise pollution inside and outside the factory premises. Noise monitoring will be carried out regularly at different parts of the plant. Pre-Feasibility Report Page | 80 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 6. PROJECT SCHEDULE & COST ESTIMATES 6.1 Schedule of Approval and Implementation The proposed project has been planned for the manufacturing of synthetic organic chemicals. The entire development will take about 1 year for the completion of proposed project. The construction activities and installation of plant & machineries will start after obtaining necessary approval from State Level Environment Impact Assessment Authority (SEIAA) and State Pollution Control Board (SPCB). 6.2 Capital Investment The proposed unit is a small scale unit with the capital investment of Rs. 800 Lacs and estimated cost of Rs. 150 Lacs towards Environmental Protection Measures. Break-up of the capital cost is given in Table - 17. Table – 17: Capital Cost Sr. No. Capital Cost (Rs. in Lacs) Description 1. Land & Site Development 100 2. Building 250 3. Environmental Protection Measures 150 4. Plant & Machineries & Other Costs 300 Total 800 Pre-Feasibility Report Page | 81 Proposed Project for Manufacturing of Synthetic Organic Chemicals M/s. Anlon Healthcare Pvt. Ltd. 7. FINAL RECOMMENDATIONS The unit will provide adequate measures for the prevention and control of pollution. With the execution and operation of such control measures along with proper Environmental Management System, there will not be any major potential for negative impact on the environment due to proposed project. On the contrary, there will be positive impact on the socio-economic environment since proposed project will generate some permanent and secondary employment. The unit will also establish Cordial relation with the nearby villagers and will carry out social welfare activities according to their needs. The proposed project will also boosts up ancillary industrial and commercial activity. Thus, it will improve the economic condition of the area. Pre-Feasibility Report Page | 82